{"generated":"2026-10-03T15:50:28-07:00","rows":[{"id":"a-emerald-valley-institute-llc-eugene","cat":"industry","name":"A Emerald Valley Institute LLC","city":"Eugene","region":"Oregon","country":"United States","cc":"US","lat":44.05193,"lon":-123.09367,"gp":"city","layer":"training","org_type":"Facilitator training program","drugs":["psilocybin"],"detail":"State-approved Oregon curriculum holder; minimal public footprint.","web":"https://emeraldvalleyinstitute.com","src":"https://psilocybin.oregon.gov/training-approved","eid":"x:org:a-emerald-valley-institute-llc-eugene"},{"id":"aaa-learning-institute-eugene","cat":"industry","name":"AAA Learning Institute","city":"Eugene","region":"Oregon","country":"United States","cc":"US","lat":44.05259,"lon":-123.07804,"gp":"city","layer":"training","org_type":"Facilitator training school","drugs":["psilocybin"],"detail":"Price-disruptor at the bottom of the Oregon training market.","web":"https://www.aaalearninginstitute.com","people":"Jen Snyder (founder)","src":"https://www.aaalearninginstitute.com/","eid":"x:org:aaa-learning-institute-eugene"},{"id":"atma-cena-psychedelic-healthcare-solutions-calgary","cat":"industry","name":"ATMA CENA Psychedelic Healthcare Solutions","city":"Calgary","region":"Alberta","country":"Canada","cc":"CA","lat":51.05355,"lon":-114.08223,"gp":"city","layer":"training","org_type":"Psychedelic healthcare company - practitioner certification + clinic network","drugs":["psilocybin","ketamine","MDMA"],"detail":"Canada's largest private psychedelic-therapy training + clinic-enablement platform under the Special Access Program regime.","phone":"+1 (888) 720-6040","web":"https://atmacena.com","people":"David Harder (founder & CEO, ATMA Journey Centers - as published in Collisions YYC episode listing)","src":"https://atmacena.com/psychedelic-therapy-training-cost-canada/","eid":"x:org:atma-cena-psychedelic-healthcare-solutions-calgary"},{"id":"atma-journey-centers-calgary-ca","cat":"industry","name":"ATMA Journey Centers","city":"Calgary","region":"AB","country":"Canada","cc":"CA","lat":51.04027,"lon":-114.07696,"gp":"city","kind":"training","drugs":["ketamine","psilocybin"],"detail":"Psychedelic-assisted therapy training (Introduction, Advanced Certification, physician/prescriber courses, CE credits); Special Access Program facilitation serv","email":"training@atmajourney.com","web":"https://atmajourney.com/","people":"David Harder (co-founder & co-CEO)","src":"https://atmajourney.com/contact/","layer":"Training programs","eid":"x:org:atma-journey-centers-calgary-ca"},{"id":"academy-of-intrinsic-studies-ais-bend","cat":"industry","name":"Academy of Intrinsic Studies (AIS)","city":"Bend","region":"Oregon","country":"United States","cc":"US","lat":44.06255,"lon":-121.31376,"gp":"city","layer":"training","org_type":"Multi-state natural-medicine training company","drugs":["psilocybin"],"detail":"Multi-state expansion play in facilitator education (CO live; OR/NM/NY planned).","phone":"(458) 206-0853 (DORA list) / +1 541-316-8846 (site)","email":"instruction@intrinsicstudies.com","web":"https://intrinsicstudies.com","src":"https://intrinsicstudies.com/","eid":"x:org:academy-of-intrinsic-studies-ais-bend"},{"id":"acadia-professional-learning-llc-portland","cat":"industry","name":"Acadia Professional Learning LLC","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52321,"lon":-122.66685,"gp":"city","layer":"training","org_type":"Facilitator training school","drugs":["psilocybin"],"detail":"One of the few dual OR+CO fully-approved (didactic+practicum+consultation) training providers.","phone":"(503) 963-7913 (as published on CO DORA list)","web":"https://acadiaprofessional.com","src":"https://dpo.colorado.gov/NaturalMedicine","eid":"x:org:acadia-professional-learning-llc-portland"},{"id":"alfred-m-hubbard-institute-san-francisco","cat":"industry","name":"Alfred M. Hubbard Institute","city":"San Francisco","region":"California","country":"United States","cc":"US","lat":37.78044,"lon":-122.42991,"gp":"city","layer":"training","org_type":"Facilitator training program","drugs":["psilocybin"],"detail":"Out-of-state (CA) holder of an approved Oregon curriculum.","web":"https://www.AlfredHubbard.com","src":"https://psilocybin.oregon.gov/training-approved","eid":"x:org:alfred-m-hubbard-institute-san-francisco"},{"id":"alma-institute-portland","cat":"industry","name":"Alma Institute","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52096,"lon":-122.66976,"gp":"city","layer":"training","org_type":"Nonprofit facilitator training school (equity-focused)","drugs":["psilocybin"],"detail":"The field's leading equity/scholarship-driven training nonprofit; bellwether for accessibility economics in facilitator training.","email":"admissions@almatraining.org (as published)","web":"https://almainstitute.org","people":"Rebecca Martinez (founder)","src":"https://psychedelicscourses.com/alma-institute-facilitator-training-program","flag":true,"eid":"x:org:alma-institute-portland"},{"id":"american-psychedelic-practitioners-association-appa-washington","cat":"industry","name":"American Psychedelic Practitioners Association (APPA)","city":"Washington","region":"DC (national)","country":"United States","cc":"US","lat":38.90052,"lon":-77.03802,"gp":"city","layer":"association","org_type":"professional association / accreditation body (nonprofit)","drugs":["psilocybin","MDMA"],"detail":"Founded 2021 as both the national practitioner association and accreditation body for psychedelic-assisted therapy; co-published (with BrainFutures) the first professional practice guidelines for PAT in Aug 2023; 1,000+ clinician members.","email":"APPA@kcsa.com","web":"https://www.appa-us.org/","people":"Stephen N. Xenakis, MD (Executive Director, appointed June 2023); Darron Smith, PhD, PA-C (Board Member)","src":"https://www.biospace.com/american-psychedelic-practitioners-association-announces-appointment-of-brigadier-general-ret-stephen-n-xenakis-md-as-new-executive-director","eid":"x:org:american-psychedelic-practitioners-association-appa-washington"},{"id":"american-society-of-ketamine-physicians-psychotherapists-practitioners-askp3-alt","cat":"industry","name":"American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3)","city":"Altamonte Springs","region":"Florida","country":"United States","cc":"US","lat":28.65476,"lon":-81.3764,"gp":"city","layer":"association","org_type":"professional society","drugs":["ketamine","esketamine"],"detail":"The main US intradisciplinary society setting evidence-based standards for ketamine therapy — the currently legal on-ramp for most psychedelic-adjacent clinics; runs education and an annual conference.","phone":"407-774-7880","email":"info@askp.org","web":"https://www.askp.org/","people":"Sandhya Prashad, MD (President); Erin Amato, MD (Vice President); Patrick Sullivan, DO (Secretary); Jeffrey Becker, MD (Treasurer); Nykol Bailey Rice, CRNA (Director); Nico Grundmann, MD, MBA…","src":"https://www.askp.org/board-members/","eid":"x:org:american-society-of-ketamine-physicians-psychotherapists-practitioners-askp3-alt"},{"id":"apollo-pact-usa","cat":"industry","name":"Apollo Pact","country":"United States","cc":"US","lat":39.0657,"lon":-77.003,"gp":"country","layer":"advocacy","org_type":"501(c)(3) patient advocacy organization","drugs":["psilocybin"],"detail":"The patient voice in federal psychedelic advocacy - clinical-trial alumni lobbying Congress to prioritize psychedelic research funding; supports the Congressional PATH Caucus","email":"hello@apollopact.org","web":"https://www.apollopact.org","people":"Jon Kostas (CEO & Founder; first participant in NYU psilocybin-for-alcohol-use-disorder RCT); Hon. Mimi Walters (Chairwoman, former U.S. Representative); Cara Zimmerman, MD (Director)","src":"https://www.apollopact.org/team","eid":"x:org:apollo-pact-usa"},{"id":"ataibeckley-atai-life-sciences-beckley-psytech-new-york","cat":"industry","name":"AtaiBeckley (atai Life Sciences + Beckley Psytech)","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.72025,"lon":-74.01693,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage platform company, Nasdaq: ATAI)","drugs":["5-MeO-DMT","DMT","MDMA"],"detail":"Largest psychedelic-platform company post-merger; BPL-003 has FDA Breakthrough Therapy designation and Phase 3 in TRD starting 2026.","web":"https://ir.ataibeckley.com","people":"Srinivas Rao, MD, PhD (CEO & Co-founder); Christian Angermayer (Chairman); Scott Braunstein, MD (Vice Chairman)","src":"https://ir.ataibeckley.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-successful","eid":"x:org:ataibeckley-atai-life-sciences-beckley-psytech-new-york"},{"id":"ataibeckley-inc-atai-life-sciences-beckley-psytech-new-york","cat":"industry","name":"AtaiBeckley Inc. (atai Life Sciences + Beckley Psytech)","city":"New York","region":"New York (US redomiciled; Beckley Psytech operations Oxford, UK)","country":"United States","cc":"US","lat":40.70453,"lon":-73.99482,"gp":"city","layer":"supplier","org_type":"clinical-stage pharma developer with in-house psychedelic API supply for trials","drugs":["5-MeO-DMT","DMT","MDMA"],"detail":"Combined entity (completed Nov 4-5, 2025) controls the mebufotenin/DMT/R-MDMA API supply used across its Phase 2/3 trials","web":"https://ir.ataibeckley.com","people":"Dr. Srinivas Rao (CEO & co-founder, atai); Cosmo Feilding Mellen (co-founder & former CEO, Beckley Psytech; board member)","src":"https://www.globenewswire.com/news-release/2025/11/05/3181304/0/en/atai-Life-Sciences-and-Beckley-Psytech-Announce-the-Successful-Completion-of-Their-Strategic-Combination-to-Create-AtaiBeckley-a-Global-Leader-in-Transformative-Mental-Health-Thera.html","eid":"x:org:ataibeckley-inc-atai-life-sciences-beckley-psytech-new-york"},{"id":"baker-donelson-baker-donelson-bearman-caldwell-berkowitz-pc-memphis","cat":"industry","name":"Baker Donelson (Baker, Donelson, Bearman, Caldwell & Berkowitz, PC)","city":"Memphis","region":"TN (20+ offices across the Southeast, TX, NJ, DC)","country":"United States","cc":"US","lat":35.14205,"lon":-90.0543,"gp":"city","layer":"legal","org_type":"BigLaw firm (cannabis, psychedelics & emerging therapies team)","drugs":["ketamine","psilocybin"],"detail":"Named 'Cannabis and Psychedelics Law and Regulation' practice advising ketamine clinics, clinical researchers, health systems and investors — a bridge between mainstream health-system counsel and the psychedelics sector.","phone":"973.218.5849","email":"lgora@bakerdonelson.com","web":"https://www.bakerdonelson.com/","people":"Lisa Gora (Shareholder, practice contact; NJ State Bar psychedelic committee member; lgora@bakerdonelson.com, 973.218.5849); Sean B. O'Connell (practice contact; soconnell@bakerdonelson.com,…","src":"https://www.bakerdonelson.com/cannabis-and-psychedelics-law-and-regulation","eid":"x:org:baker-donelson-baker-donelson-bearman-caldwell-berkowitz-pc-memphis"},{"id":"berkeley-center-for-the-science-of-psychedelics-bcsp-psychedelic-facilitation-ce","cat":"industry","name":"Berkeley Center for the Science of Psychedelics (BCSP) - Psychedelic Facilitation Certificate","city":"Berkeley","region":"California","country":"United States","cc":"US","lat":37.87352,"lon":-122.26433,"gp":"city","layer":"training","org_type":"University certificate program (UC Berkeley)","drugs":["psilocybin"],"detail":"Elite-university facilitation certificate whose spin-out marks the professionalization of chaplaincy/facilitator training.","email":"psychedelic-certificate@berkeley.edu","web":"https://psychedelics.berkeley.edu/training/","people":"Moana Meadow (Program Staff Director); Tina Trujillo (Faculty Director); Sylver Quevedo, MD (Senior Scholar, core instructor)","src":"https://psychedelics.berkeley.edu/training/","eid":"x:org:berkeley-center-for-the-science-of-psychedelics-bcsp-psychedelic-facilitation-ce"},{"id":"board-of-psychedelic-medicine-and-therapies-bpmt-usa","cat":"industry","name":"Board of Psychedelic Medicine and Therapies (BPMT)","region":"California","country":"United States","cc":"US","lat":35.5165,"lon":-119.0662,"gp":"region","layer":"association","org_type":"certification/credentialing board (CA nonprofit public benefit corp)","detail":"Building national certification standards for psychedelic therapists — the would-be 'board certification' layer of the profession; fiscally sponsored by Players Philanthropy Fund (501(c)(3)).","web":"https://psychedelicsboard.org/","people":"NiCole T. Buchanan, PhD (Interim Board Chair and CEO); Kirk Marckwald (former Interim Executive Director)","src":"https://psychedelicsboard.org/about/","eid":"x:org:board-of-psychedelic-medicine-and-therapies-bpmt-usa"},{"id":"bodhi-academy-boulder","cat":"industry","name":"Bodhi Academy","city":"Boulder","region":"Colorado","country":"United States","cc":"US","lat":40.00299,"lon":-105.27766,"gp":"city","layer":"training","org_type":"Facilitator training school","drugs":["psilocybin"],"detail":"Boulder-based fully-approved (all three components) Colorado training provider with retreat-based practicum.","phone":"(720) 372-1158 (as published on CO DORA list)","email":"training@bodhi-academy.com","web":"https://www.bodhi-academy.com","people":"Team incl. Sienna Terranova, LNMF, CICC, CBHT; Anthony Smith, PhD; Rose Moulin-Franco, LNMF, CPC, CICMC (founders not specified on site)","src":"https://www.bodhi-academy.com/","eid":"x:org:bodhi-academy-boulder"},{"id":"breaking-convention-united-kingdom","cat":"industry","name":"Breaking Convention","region":"England (2025 edition: University of Exeter)","country":"United Kingdom","cc":"GB","lat":51.0085,"lon":-0.3316,"gp":"country","layer":"association","org_type":"conference organizer (UK registered charity #1159687)","detail":"Europe's leading biennial psychedelic research conference (since 2011, 200+ presenters, attendees from 40 countries); also publishes academic volumes from each conference; BC2025 held April 17–19 at University of Exeter.","email":"info@breakingconvention.co.uk","web":"https://breakingconvention.co.uk/","people":"Aimee Tollan (Executive Director); Alexander Beiner (Executive Director); Hattie Wells (Executive Director); Nikki Wyrd (Executive Director); Peter Sjöstedt-Hughes (Executive Director); Cameron…","src":"https://breakingconvention.co.uk/about","eid":"x:org:breaking-convention-united-kingdom"},{"id":"bright-minds-biosciences-vancouver","cat":"industry","name":"Bright Minds Biosciences","city":"Vancouver","region":"British Columbia","country":"Canada","cc":"CA","lat":49.2547,"lon":-123.12579,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage, Nasdaq: DRUG)","detail":"Psychedelic-derived serotonin pharmacology pivoted to epilepsy: positive Phase 2 BREAKTHROUGH data (Jan 2026) now heading to registrational trials.","web":"https://brightmindsbio.com","people":"Ian McDonald (CEO & Co-founder); Stephen Collins, MD, PhD (Chief Medical Officer, appointed Aug 2025)","src":"https://www.globenewswire.com/news-release/2026/01/06/3213483/0/en/Bright-Minds-Biosciences-Announces-Positive-Topline-Results-from-Phase-2-Clinical-Trial-of-BMB-101-in-Patients-with-Absence-Seizures-and-Developmental-and-Encephalopathic-Epilepsie.html","eid":"x:org:bright-minds-biosciences-vancouver"},{"id":"cb-therapeutics-inc-carlsbad-san-diego-area","cat":"industry","name":"CB Therapeutics Inc.","city":"Carlsbad (San Diego area)","region":"California","country":"United States","cc":"US","lat":33.15164,"lon":-117.35666,"gp":"city","layer":"supplier","org_type":"biosynthesis / precision-fermentation manufacturer of tryptamines and cannabinoids","drugs":["psilocybin"],"detail":"Patented yeast-fermentation route to psilocybin/tryptamines - an alternative supply technology to synthesis or cultivation for research supply","phone":"+1 (833) 322-8437","web":"https://www.cbthera.com","people":"Sher Ali Butt (co-founder & CEO); Jacob Vogan (co-founder & CSO)","src":"https://www.cbthera.com/","eid":"x:org:cb-therapeutics-inc-carlsbad-san-diego-area"},{"id":"ciis-center-for-psychedelic-therapies-and-research-california-institute-of-integ-2","cat":"industry","name":"CIIS Center for Psychedelic Therapies and Research (California Institute of Integral Studies)","city":"San Francisco","region":"California","country":"United States","cc":"US","lat":37.77978,"lon":-122.41674,"gp":"city","layer":"training","org_type":"University continuing-education certificate program","drugs":["psilocybin","MDMA","ketamine"],"detail":"The original academic psychedelic-therapy certificate; trained much of the field's first generation of US therapists.","phone":"628-279-0871","email":"kpamarang@ciis.edu (Assistant Director of Admissions)","web":"https://www.ciis.edu/continuing-education/center-for-psychedelic-therapies-and-research","people":"Janis Phelps, PhD (Founding Director, per CIIS center pages); Kelson Pamarang (Assistant Director of Admissions for Certificate Programs)","src":"https://www.ciis.edu/continuing-education/center-for-psychedelic-therapies-and-research/about-the-certificate","eid":"x:org:ciis-center-for-psychedelic-therapies-and-research-california-institute-of-integ-2"},{"id":"cu-denver-center-for-psychedelic-research-cpr-facilitator-training-program-denve","cat":"industry","name":"CU Denver Center for Psychedelic Research - CPR Facilitator Training Program","city":"Denver","region":"Colorado","country":"United States","cc":"US","lat":39.73656,"lon":-104.98983,"gp":"city","layer":"training","org_type":"Public university facilitator training program","drugs":["psilocybin"],"detail":"The public-university option in Colorado's approved-training roster.","email":"facilitator.training@ucdenver.edu","web":"https://clas.ucdenver.edu/education-and-training-psychedelic-science-and-facilitation","src":"https://clas.ucdenver.edu/education-and-training-psychedelic-science-and-facilitation","eid":"x:org:cu-denver-center-for-psychedelic-research-cpr-facilitator-training-program-denve"},{"id":"calyx-law-llp-san-francisco","cat":"industry","name":"Calyx Law LLP","city":"San Francisco","region":"CA (second office: Boston, MA)","country":"United States","cc":"US","lat":37.77884,"lon":-122.42323,"gp":"city","layer":"legal","org_type":"IP/patent law boutique (cannabis & psychedelics)","drugs":["psilocybin"],"detail":"Founded 2016; the premier patent/IP boutique for psychedelics ventures — patent strategy, prosecution and freedom-to-operate for psychedelic drug developers; Pechenik also tracks psychedelic patent activity publicly.","web":"https://calyx.law/","people":"Graham Pechenik (Founding Partner; registered patent attorney; Psychedelic Bar Association board member); Frank Gerratana (Partner, Boston); Ariel Donthnier Waagosh (Of Counsel, regulatory); Chris…","src":"https://calyx.law/","eid":"x:org:calyx-law-llp-san-francisco"},{"id":"caretaker-medical-charlottesville","cat":"industry","name":"Caretaker Medical","city":"Charlottesville","region":"Virginia","country":"United States","cc":"US","lat":38.02371,"lon":-78.4691,"gp":"city","layer":"tech","org_type":"wireless vital-signs monitoring device manufacturer","drugs":["ketamine"],"detail":"Owns in-session patient-safety hardware: VitalStream, an FDA-cleared wireless wearable continuous beat-by-beat blood pressure/cardiac-output monitor marketed directly to ketamine and psychedelic therapy clinics (90-second setup, multi-room VitalStation, EMR…","phone":"+1 434-978-7000","email":"info@caretakermedical.net","web":"https://caretakermedical.net/","people":"Jeff Pompeo (President & CEO, per company LinkedIn)","src":"https://caretakermedical.net/ketamine-blood-pressure-monitoring/","eid":"x:org:caretaker-medical-charlottesville"},{"id":"center-for-medicinal-mindfulness-medicinal-mindfulness-academy-boulder","cat":"industry","name":"Center for Medicinal Mindfulness (Medicinal Mindfulness Academy)","city":"Boulder","region":"Colorado","country":"United States","cc":"US","lat":40.01071,"lon":-105.27464,"gp":"city","layer":"training","org_type":"Psychedelic therapy center + DORA-approved training academy","drugs":["psilocybin"],"detail":"Longest-running Boulder psychedelic-guide lineage converted into a fully-approved Colorado training program.","phone":"720-440-1067 (as published on CO DORA list)","web":"https://medicinalmindfulness.academy","people":"Daniel McQueen, MA (founder/lead); Alison McQueen, LPC, ATR-BC, ACS (co-lead)","src":"https://medicinalmindfulness.academy/","eid":"x:org:center-for-medicinal-mindfulness-medicinal-mindfulness-academy-boulder"},{"id":"ceremonia-ceremonia-edu-arvada-training-listing-denver","cat":"industry","name":"Ceremonia (Ceremonia Edu)","city":"Arvada (training listing) / Denver","region":"Colorado","country":"United States","cc":"US","lat":39.89,"lon":-105.2018,"gp":"region","layer":"training","org_type":"508(c)(1)(a) church nonprofit with DORA-approved facilitator training","drugs":["psilocybin"],"detail":"Church-model operator that crossed into state-approved facilitator education - a distinctive legal posture.","phone":"720-460-1630 (as published on CO DORA list)","web":"https://www.ceremoniacircle.org","people":"Austin Mao (co-founder)","src":"https://dpo.colorado.gov/NaturalMedicine","eid":"x:org:ceremonia-ceremonia-edu-arvada-training-listing-denver"},{"id":"changa-institute-lake-oswego-portland","cat":"industry","name":"Changa Institute","city":"Lake Oswego / Portland","region":"Oregon","country":"United States","cc":"US","lat":45.2049,"lon":-122.3487,"gp":"region","layer":"training","org_type":"Private multi-state facilitator training school","drugs":["psilocybin"],"detail":"Aggressive multi-state (OR/CO/NM) training operator tracking each new legalization market.","phone":"970-904-0071 (as published on CO DORA list)","web":"https://www.changainstitute.com","people":"Lisa Ginzburg (founder & director, per PsychedelicNewsWire)","src":"https://www.changainstitute.com/programs/oregon-certification","eid":"x:org:changa-institute-lake-oswego-portland"},{"id":"colorado-natural-medicine-division-department-of-revenue-denver","cat":"industry","name":"Colorado Natural Medicine Division (Department of Revenue)","city":"Denver","region":"Colorado","country":"United States","cc":"US","lat":39.72781,"lon":-104.97863,"gp":"city","layer":"regulator","org_type":"state regulatory division (business/product licensing)","drugs":["psilocybin"],"detail":"Licenses and regulates Colorado natural-medicine businesses — healing centers, cultivation, manufacturing, testing — under Proposition 122; began accepting license applications Dec 31, 2024.","email":"dominique.mendiola@state.co.us","web":"https://nmd.colorado.gov/","people":"Dominique Mendiola (Senior Director, Marijuana Enforcement and Natural Medicine Divisions)","src":"https://nmd.colorado.gov/about-us","eid":"x:org:colorado-natural-medicine-division-department-of-revenue-denver"},{"id":"colorado-natural-medicine-program-dora-division-of-professions-and-occupations-d","cat":"industry","name":"Colorado Natural Medicine Program — DORA Division of Professions and Occupations","city":"Denver","region":"Colorado","country":"United States","cc":"US","lat":39.72819,"lon":-104.98202,"gp":"city","layer":"regulator","org_type":"state facilitator-licensing office","drugs":["psilocybin"],"detail":"The professional-licensing half of Colorado's system: licenses natural medicine facilitators (and their training/CE requirements) at DORA, complementing DOR's business licensing — gatekeeper for the facilitator workforce.","phone":"303-894-7800","email":"dora_natural_medicine@state.co.us","web":"https://dpo.colorado.gov/NaturalMedicine","people":"Lorey Bratten (Program Director)","src":"https://dpo.colorado.gov/NaturalMedicine","eid":"x:org:colorado-natural-medicine-program-dora-division-of-professions-and-occupations-d"},{"id":"compass-pathways-london","cat":"industry","name":"Compass Pathways","city":"London","region":"England","country":"United Kingdom","cc":"GB","lat":51.50349,"lon":-0.12955,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage, Nasdaq: CMPS)","drugs":["psilocybin"],"detail":"Front-runner: two positive Phase 3 trials (COMP005, COMP006) in treatment-resistant depression; likely first psilocybin NDA.","web":"https://compasspathways.com","people":"Kabir Nath (CEO); Guy Goodwin (Chief Medical Officer)","src":"https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-FDA-Granted-NDA-Rolling-Review-Request-and-Awarded-Commissioners-National-Priority-Voucher/default.aspx","eid":"x:org:compass-pathways-london"},{"id":"compass-pathways-u-s-comp360-provider-training-grant-program-usa","cat":"industry","name":"Compass Pathways - U.S. COMP360 Provider Training Grant Program","region":"US program (Compass HQ London/New York)","country":"United States","cc":"US","lat":39.3481,"lon":-76.5638,"gp":"country","layer":"training","org_type":"Pharma-funded provider-training grant program","drugs":["psilocybin"],"detail":"The vehicle that will anoint up to 3 training orgs for FDA-era psilocybin therapy delivery - the biggest near-term prize in the training layer.","web":"https://ir.compasspathways.com","src":"https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-U-S-Grant-Program-for-the-Creation-of-Post-Approval-COMP360-Provider-Training/default.aspx","eid":"x:org:compass-pathways-u-s-comp360-provider-training-grant-program-usa"},{"id":"compass-pathways-plc-london","cat":"industry","name":"Compass Pathways plc","city":"London","region":"England","country":"United Kingdom","cc":"GB","lat":51.50745,"lon":-0.13228,"gp":"city","layer":"supplier","org_type":"pharmaceutical developer with proprietary in-house COMP360 psilocybin API/drug product supply","drugs":["psilocybin"],"detail":"Controls the largest proprietary psilocybin supply chain in the industry - COMP360 GMP polymorph manufactured for its Phase 3 TRD/PTSD program (1000+ participants)","web":"https://compasspathways.com","people":"Kabir Nath (CEO); George Goldsmith (co-founder); Ekaterina Malievskaia (co-founder)","src":"https://compasspathways.com/about-us/","eid":"x:org:compass-pathways-plc-london"},{"id":"definium-therapeutics-fka-mindmed-mind-medicine-new-york","cat":"industry","name":"Definium Therapeutics (fka MindMed / Mind Medicine)","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.72213,"lon":-74.00771,"gp":"city","layer":"developer","org_type":"pharma (late-clinical-stage, Nasdaq: DFTX)","drugs":["LSD"],"detail":"Only company with LSD in pivotal trials: three Phase 3 readouts expected in 2026 across GAD and MDD; Breakthrough Therapy designation in GAD.","web":"https://definiumtx.com","people":"Robert (Rob) Barrow (CEO, since 2021); Daniel R. Karlin, MD (Chief Medical Officer)","src":"https://www.businesswire.com/news/home/20260109339960/en/MindMed-Rebrands-to-Definium-Therapeutics-Advancing-a-Leading-Late-Stage-Psychiatry-Pipeline-with-Three-Phase-3-Readouts-Expected-in-2026","eid":"x:org:definium-therapeutics-fka-mindmed-mind-medicine-new-york"},{"id":"delix-therapeutics-boston","cat":"industry","name":"Delix Therapeutics","city":"Boston","region":"Massachusetts","country":"United States","cc":"US","lat":42.36836,"lon":-71.06998,"gp":"city","layer":"developer","org_type":"pharma (private, clinical-stage)","drugs":["DMT"],"detail":"Flagship of the non-hallucinogenic neuroplastogen class: Phase 1b efficacy signal in MDD and FDA-cleared Phase 2 design allowing at-home self-administration.","email":"info@delixtherapeutics.com","web":"https://www.delixtherapeutics.com","people":"Mark Rus (President & CEO); David E. Olson, PhD (Co-founder; neuroplastogen concept originator)","src":"https://www.biospace.com/press-releases/delix-therapeutics-announces-positive-efficacy-data-for-dlx-001-zalsupindole-and-fda-clearance-of-phase-ii-trial-design-featuring-at-home-administration","eid":"x:org:delix-therapeutics-boston"},{"id":"drug-policy-alliance-new-york","cat":"industry","name":"Drug Policy Alliance","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.71112,"lon":-73.99745,"gp":"city","layer":"advocacy","org_type":"501(c)(3) nonprofit (drug policy reform)","drugs":["LSD","psilocybin","MDMA"],"detail":"Historic heavyweight of drug policy reform whose psychedelics work spans decriminalization advocacy, harm-reduction at venues, drug fact-sheets, and removing research barriers; a coalition anchor rather than a psychedelics-specialist shop.","web":"https://drugpolicy.org/","people":"Kassandra Frederique (Executive Director since Sept 2020)","src":"https://drugpolicy.org/","eid":"x:org:drug-policy-alliance-new-york"},{"id":"druids-choice-aurora","cat":"industry","name":"Druids Choice","city":"Aurora","region":"Colorado","country":"United States","cc":"US","lat":39.71856,"lon":-104.82952,"gp":"city","layer":"supplier","org_type":"Colorado NMD-licensed natural medicine cultivation facility","drugs":["psilocybin"],"detail":"Second cultivation licensed under Colorado's Natural Medicine program (April 2025); began inoculation May 2025","people":"Adrian Martinez (owner)","src":"https://coloradosun.com/2025/05/29/psilocybin-healing-industry-colorado-regulations/","eid":"x:org:druids-choice-aurora"},{"id":"elemental-psychedelics-fort-collins","cat":"industry","name":"Elemental Psychedelics","city":"Fort Collins","region":"Colorado","country":"United States","cc":"US","lat":40.57806,"lon":-105.08814,"gp":"city","layer":"training","org_type":"DORA-approved facilitator training school","drugs":["psilocybin"],"detail":"Northern-Colorado fully-approved training provider with embodied/experiential emphasis.","phone":"(970) 818-8346 (as published on CO DORA list)","web":"https://www.elementalpsychedelics.com","people":"Shannon Hughes, PhD (Program Director); Dori Lewis, LPC (Therapist & Clinical Director)","src":"https://www.elementalpsychedelics.com/mushroomtraining","eid":"x:org:elemental-psychedelics-fort-collins"},{"id":"empatica-cambridge-boston","cat":"industry","name":"Empatica","city":"Cambridge (Boston)","region":"Massachusetts","country":"United States","cc":"US","lat":42.3743,"lon":-71.10933,"gp":"city","layer":"tech","org_type":"medical wearable / digital-biomarker platform","detail":"Owns research-grade wearable biometrics for trials: FDA-cleared EmbracePlus smartwatch (100+ digital measures, EDA/sleep/actigraphy) + Health Monitoring Platform; selected as technology partner for the US DoD/USAMMDA Phase 2 PTSD pharmacotherapy study (Feb…","email":"info@empatica.com","web":"https://www.empatica.com/","people":"Matteo Lai (co-founder & CEO); Rosalind Picard, ScD (founder & Chief Scientist, MIT Media Lab); Simone Tognetti, PhD (co-founder & CTO); Maurizio Garbarino, PhD (co-founder, Chief Software Architect)","src":"https://www.empatica.com/about/","eid":"x:org:empatica-cambridge-boston"},{"id":"entheogen-institute-ashland","cat":"industry","name":"Entheogen Institute","city":"Ashland","region":"Oregon","country":"United States","cc":"US","lat":37.69244,"lon":-122.1234,"gp":"city","layer":"training","org_type":"Facilitator training school","drugs":["psilocybin"],"detail":"Dual-state approved southern-Oregon training provider.","phone":"541-690-4786 (as published on CO DORA list)","web":"https://www.entheotraining.com","src":"https://dpo.colorado.gov/NaturalMedicine","eid":"x:org:entheogen-institute-ashland"},{"id":"enveric-biosciences-cambridge","cat":"industry","name":"Enveric Biosciences","city":"Cambridge","region":"Massachusetts","country":"United States","cc":"US","lat":42.38663,"lon":-71.11545,"gp":"city","layer":"developer","org_type":"pharma (preclinical/IND-stage, Nasdaq: ENVB)","detail":"Small-cap neuroplastogen developer with a Psybrary(TM) discovery platform; EB-003 in IND-enabling studies aiming for first-in-human entry.","web":"https://www.enveric.com","people":"Joseph Tucker, PhD (CEO & Director)","src":"https://www.businesswire.com/news/home/20260602535123/en/Enveric-Biosciences-Initiates-Investigational-New-Drug-IND-enabling-Genotoxicity-Studies-of-Lead-Neuroplastogen-Candidate-EB-003","eid":"x:org:enveric-biosciences-cambridge"},{"id":"epstein-becker-green-p-c-washington","cat":"industry","name":"Epstein Becker & Green, P.C.","city":"Washington","region":"DC (psychedelics contacts in DC and Portland, OR)","country":"United States","cc":"US","lat":38.90005,"lon":-77.04282,"gp":"city","layer":"legal","org_type":"Health care law firm (psychedelics industry practice)","drugs":["psilocybin","DMT","ketamine","LSD","MDMA","ibogaine"],"detail":"Health care 'super boutique' covering the full psychedelic medicine lifecycle — INDs/NDAs, REMS, Oregon PSA and Colorado NMHA programs, ketamine clinic operations, corporate practice of medicine; picked up Emerge's Kaci Hohmann when that firm closed.","phone":"202-861-1891","web":"https://www.ebglaw.com/","people":"James A. Boiani (Member of the Firm, Washington DC; regulatory strategy/product approvals; 202-861-1891); Kaci Hohmann (Senior Counsel, Portland OR; corporate & transactional; ex-Emerge Law Group;…","src":"https://www.ebglaw.com/industries/life-sciences-industry/psychedelics","eid":"x:org:epstein-becker-green-p-c-washington"},{"id":"feldman-legal-advisors-pllc-usa","cat":"industry","name":"Feldman Legal Advisors PLLC","region":"US (office city not published on cited pages; David Feldman is New York-based per public profiles)","country":"United States","cc":"US","lat":38.7637,"lon":-76.6972,"gp":"country","layer":"legal","org_type":"Corporate/securities law boutique (cannabis & psychedelics)","drugs":["psilocybin","mescaline","ibogaine","DMT"],"detail":"This is the 'Feldmann' target, verified as Feldman Legal Advisors — Chambers-ranked in Psychedelics Law; combines corporate/securities work with Colorado natural-medicine licensing and FDA/DEA pathway counsel for novel compounds.","email":"cbarnes@feldmanlegaladvisors.com","web":"https://www.feldmanlegaladvisors.com/","people":"David Feldman (Founder & Managing Partner; corporate/securities and M&A; Global Top 200 Psychedelics Lawyer 2024-2025; dfeldman@feldmanlegaladvisors.com); Courtney Barnes (Partner, psychedelics…","src":"https://www.feldmanlegaladvisors.com/psychedelics-law","eid":"x:org:feldman-legal-advisors-pllc-usa"},{"id":"filament-health-burnaby","cat":"industry","name":"Filament Health","city":"Burnaby","region":"British Columbia","country":"Canada","cc":"CA","lat":49.27761,"lon":-122.94261,"gp":"city","layer":"supplier","org_type":"botanical GMP psychedelic drug manufacturer/developer (subsidiary of Red Light Holland); also botanical drug developer (subsidiary of Rhelion Life Sciences, formerly Red Light Holland)","drugs":["psilocybin"],"detail":"Leading exclusively-natural GMP psilocybin supplier to FDA/international trials; first GMP natural psilocybin export to the US","email":"hello@filament.health","web":"https://filament.health","people":"Benjamin Lightburn (co-founder & CEO)","src":"https://filament.health/","eid":"x:org:filament-health-burnaby"},{"id":"fluence-fluence-international-inc-new-york-bronx-address-on-co-dora-list","cat":"industry","name":"Fluence (Fluence International, Inc.)","city":"New York (Bronx address on CO DORA list)","region":"New York","country":"United States","cc":"US","lat":40.72382,"lon":-74.00188,"gp":"city","layer":"training","org_type":"Private psychedelic-therapy education company","drugs":["psilocybin","ketamine"],"detail":"One of the two or three largest independent psychedelic training companies; DORA-approved and positioned for post-approval pharma training partnerships.","phone":"917-719-1079 (as published on CO DORA training-program list)","email":"info@fluencetraining.com","web":"https://www.fluencetraining.com","people":"Elizabeth Nielson, PhD (CEO & co-founder)","src":"https://www.fluencetraining.com/about/news/announcing-the-certificate-in-psychedelic-therapy-and-integration","eid":"x:org:fluence-fluence-international-inc-new-york-bronx-address-on-co-dora-list"},{"id":"foley-lardner-llp-washington","cat":"industry","name":"Foley & Lardner LLP","city":"Washington","region":"DC (firm HQ Milwaukee, WI; psychedelics authors in DC and Denver)","country":"United States","cc":"US","lat":38.89196,"lon":-77.03021,"gp":"city","layer":"legal","org_type":"BigLaw firm (FDA/health care practice publishing psychedelics alerts)","drugs":["psilocybin","MDMA","DMT","LSD"],"detail":"Major FDA-regulatory group actively publishing on the Apr 18 2026 psychedelics executive order (priority vouchers, Right to Try, ARPA-H state funding) — signals BigLaw client demand from drug developers and providers.","phone":"202.672.5430","web":"https://www.foley.com/","people":"David L. Rosen (Partner, Washington DC; co-author 'Psychedelics and the Executive Order: From Schedule I to Treatment Priority', Apr 28 2026, and 'Psychedelic Drugs – Easing the Regulatory Hurdles…","src":"https://www.foley.com/insights/publications/2026/04/psychedelics-and-the-executive-order-from-schedule-i-to-treatment-priority/","eid":"x:org:foley-lardner-llp-washington"},{"id":"gh-research-dublin","cat":"industry","name":"GH Research","city":"Dublin","region":"Leinster","country":"Ireland","cc":"IE","lat":53.32765,"lon":-6.23905,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage, Nasdaq: GHRS)","drugs":["5-MeO-DMT","DMT"],"detail":"Inhaled 5-MeO-DMT leader: Phase 2b in TRD published in JAMA Psychiatry (-15.5 MADRS at Day 8); global Phase 3 initiating 2026.","web":"https://www.ghres.com","people":"Dr. Velichka 'Villy' Valcheva (CEO since Sep 2024; previously CMO)","src":"https://investor.ghres.com/news-releases/news-release-details/gh-research-announces-fda-lifts-clinical-hold-gh001-clearing/","eid":"x:org:gh-research-dublin"},{"id":"gilgamesh-pharmaceuticals-new-york","cat":"industry","name":"Gilgamesh Pharmaceuticals","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.70763,"lon":-74.01675,"gp":"city","layer":"developer","org_type":"pharma (private, clinical-stage)","drugs":["ibogaine","MDA"],"detail":"Validation case for the sector: sold Phase 2 asset bretisilocin (MDD) to AbbVie in Aug 2025 while advancing an NIDA-funded ibogaine analog for opioid use disorder.","web":"https://www.gilgameshpharmaceutical.com","people":"Jonathan Sporn, MD (CEO & Chairman, Co-founder); Andrew Kruegel, PhD (Co-founder, chemistry lead/CSO); Dalibor Sames, PhD (Co-founder)","src":"https://news.abbvie.com/2025-08-25-AbbVie-to-Acquire-Gilgamesh-Pharmaceuticals-Bretisilocin,-a-Novel,-Investigational-Therapy-for-Major-Depressive-Disorder,-Expanding-Psychiatry-Pipeline","eid":"x:org:gilgamesh-pharmaceuticals-new-york"},{"id":"harris-sliwoski-llp-portland","cat":"industry","name":"Harris Sliwoski LLP","city":"Portland","region":"OR (also Seattle, Denver, LA, Phoenix; intl: Barcelona, Lisbon, Madrid, Sydney, Mexico City)","country":"United States","cc":"US","lat":45.51512,"lon":-122.6724,"gp":"city","layer":"legal","org_type":"Law firm (international boutique; psychedelics + psilocybin practice, Psychedelics Law Blog)","drugs":["psilocybin","ketamine","ayahuasca"],"detail":"Writing about and practicing psychedelics law since 2018; serves Oregon M109 licensees, investors, retreats, and drug developers; its Psychedelics Law Blog is a leading industry legal information source.","phone":"1-888-330-0010","email":"firm@harris-sliwoski.com","web":"https://harris-sliwoski.com/","people":"Vince Sliwoski (Partner, Portland; leads psychedelics practice and edits the Psychedelics Law Blog; Top 200 Global Psychedelic Lawyer); Jason Adelstone (Partner); Frederic Rocafort (Partner); Mathew…","src":"https://harris-sliwoski.com/practice-areas/psychedelics/","eid":"x:org:harris-sliwoski-llp-portland"},{"id":"heal-ukraine-trauma-hut","cat":"industry","name":"Heal Ukraine Trauma (HUT)","kind":"training","drugs":["ketamine"],"legal":"gov_approved_treatment","basis":"Trains licensed Ukrainian clinicians in ketamine-assisted psychotherapy delivered legally in registered Ukrainian clinic","basis_src":"operator_stated","detail":"US non-profit partnered with Fluence: trained 24 Ukrainian psychiatrists/psychologists (8 pilot + 16 in 2025) now delivering group KAP to veterans under interna","web":"https://healtraumas.org/","src":"https://healtraumas.org/our-work","layer":"Training programs","eid":"x:org:heal-ukraine-trauma-hut"},{"id":"heal-ukraine-trauma-heal-traumas-international-inc-ua","cat":"industry","name":"Heal Ukraine Trauma (Heal Traumas International, Inc.)","country":"Ukraine","cc":"UA","lat":50.0684,"lon":30.5062,"gp":"country","kind":"training","drugs":["ketamine"],"detail":"Built Ukraine's first ketamine-assisted psychotherapy training program and group-based PAT model for veterans; 24 trained clinicians delivering G-KAP as of 2025","web":"https://healtraumas.org","people":"Oksana Gryshchenko, Amy Goodrich, Dr. Simon Ruffell","src":"https://healtraumas.org/our-work","layer":"Training programs","eid":"x:org:heal-ukraine-trauma-heal-traumas-international-inc-ua"},{"id":"healing-advocacy-fund-portland","cat":"industry","name":"Healing Advocacy Fund","city":"Portland","region":"OR (programs in Oregon, Colorado, New Mexico)","country":"United States","cc":"US","lat":45.51333,"lon":-122.67861,"gp":"city","layer":"advocacy","org_type":"501(c)(3) nonprofit (state-regulated psychedelic therapy advocacy)","drugs":["psilocybin"],"detail":"The lead nonprofit defending and expanding Oregon's and Colorado's regulated psilocybin/natural-medicine programs and supporting new states (New Mexico) — the key policy counterpart for service centers, facilitators, and regulators.","web":"https://healingadvocacyfund.org/","people":"Taylor West (Executive Director); Heidi Pendergast (Oregon Director); Tasia Poinsatte (Colorado Director); Denali Wilson (New Mexico Director of Strategic Support); Leslie Carlson (National…","src":"https://healingadvocacyfund.org/about-haf","eid":"x:org:healing-advocacy-fund-portland"},{"id":"healing-advocacy-fund-usa","cat":"industry","name":"Healing Advocacy Fund","region":"OR / CO / NM","country":"United States","cc":"US","lat":39.3794,"lon":-77.454,"gp":"country","layer":"advocacy","org_type":"501(c)(3) nonprofit (state-regulated program advocacy)","drugs":["psilocybin"],"detail":"The dedicated defender/expander of state-regulated psilocybin therapy - formed after Oregon Measure 109 to protect implementation, now the key advocacy layer for the OR/CO/NM supported-adult-use markets","web":"https://healingadvocacyfund.org","people":"Taylor West (Executive Director); Heidi Pendergast (Oregon Director); Tasia Poinsatte (Colorado Director); Denali Wilson (New Mexico Director of Strategic Support); Leslie Carlson (National…","src":"https://healingadvocacyfund.org/about-haf","eid":"x:org:healing-advocacy-fund-usa"},{"id":"healing-breakthrough-usa","cat":"industry","name":"Healing Breakthrough","region":"DC (federal focus)","country":"United States","cc":"US","lat":38.9441,"lon":-77.5364,"gp":"country","layer":"advocacy","org_type":"nonprofit program (federal advocacy, now a program of Heroic Hearts Project)","drugs":["MDMA","psilocybin"],"detail":"Leading federal advocacy vehicle for veteran access to MDMA-assisted therapy through the VA; secured first-ever Congressional appropriation for large-scale VA MDMA-AT trials","web":"https://www.healingbreakthrough.org","people":"Juliana Mercer (Executive Director; Marine Corps veteran)","src":"https://www.healingbreakthrough.org/","eid":"x:org:healing-breakthrough-usa"},{"id":"health-canada-special-access-program-drugs-ottawa","cat":"industry","name":"Health Canada — Special Access Program (Drugs)","city":"Ottawa","region":"Ontario","country":"Canada","cc":"CA","lat":45.41508,"lon":-75.70137,"gp":"city","layer":"regulator","org_type":"federal drug-access program office","drugs":["psilocybin","MDMA"],"detail":"Since the Jan 2022 regulatory amendment, practitioners can request restricted drugs incl. psilocybin through SAP when trials are unsuitable — Canada's main legal supply pathway and the office GMP suppliers ship against.","phone":"613-941-2108","email":"sapd-pasm@hc-sc.gc.ca","web":"https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs.html","src":"https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs.html","eid":"x:org:health-canada-special-access-program-drugs-ottawa"},{"id":"heffter-research-institute-santa-fe","cat":"industry","name":"Heffter Research Institute","city":"Santa Fe","region":"New Mexico","country":"United States","cc":"US","lat":35.68778,"lon":-105.92655,"gp":"city","layer":"funder","org_type":"Nonprofit scientific research funder, 501(c)(3)","drugs":["psilocybin"],"detail":"Primary funder of academic psilocybin research for 30+ years — 156 funded projects, incl. the foundational Hopkins/NYU/UCLA/Zurich clinical studies.","web":"https://www.heffter.org","people":"Carey Turnbull (President); George Greer, MD (Board Chair; co-founder, former Medical Director); David E. Nichols, PhD (Vice-President; co-founder)","src":"https://www.heffter.org/news/","eid":"x:org:heffter-research-institute-santa-fe"},{"id":"helus-pharma-fka-cybin-toronto","cat":"industry","name":"Helus Pharma (fka Cybin)","city":"Toronto","region":"Ontario","country":"Canada","cc":"CA","lat":43.71674,"lon":-79.38833,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage, Nasdaq/Cboe Canada: HELP)","drugs":["psilocybin","DMT"],"detail":"Late-stage psychedelic developer: HLP003 in pivotal Phase 3 (PARADIGM program) for adjunctive MDD with Breakthrough Therapy designation.","web":"https://ir.helus.com","people":"Michael Halstead (CEO, appointed Aug 2026); Eric So (Co-founder & President, interim CEO Sep 2025–Aug 2026); Amir Inamdar (Chief Medical Officer)","src":"https://www.sec.gov/Archives/edgar/data/1833141/000183314126000002/helusrebrandprfinal.htm","eid":"x:org:helus-pharma-fka-cybin-toronto"},{"id":"heroic-hearts-process-psychedelic-coach-facilitator-training-heroic-hearts-proje","cat":"industry","name":"Heroic Hearts Process Psychedelic Coach & Facilitator Training (Heroic Hearts Project)","region":"Oregon (online delivery)","country":"United States","cc":"US","lat":38.4226,"lon":-77.0815,"gp":"country","layer":"training","org_type":"Veteran-focused nonprofit training program (online)","drugs":["psilocybin"],"detail":"Veteran-community pipeline into licensed facilitation - a key access constituency.","web":"https://heroicheartsproject.learnworlds.com/","src":"https://psilocybin.oregon.gov/training-approved","eid":"x:org:heroic-hearts-process-psychedelic-coach-facilitator-training-heroic-hearts-proje"},{"id":"heroic-hearts-project-new-york","cat":"industry","name":"Heroic Hearts Project","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.71902,"lon":-74.00818,"gp":"city","layer":"funder","org_type":"501(c)(3) nonprofit (veteran treatment grantmaker + advocacy)","drugs":["ayahuasca","psilocybin","ketamine","ibogaine"],"detail":"Largest veteran psychedelic-retreat funder (1,500+ veterans/spouses served, $20M+ raised); demand-side funder and political cover for the field","email":"press@heroicheartsproject.org","web":"https://heroicheartsproject.org","people":"Jesse Gould (Founder & President); Juliana Mercer (Executive Director, Healing Breakthrough program)","src":"https://heroicheartsproject.org/about/","eid":"x:org:heroic-hearts-project-new-york"},{"id":"homecoming-homecoming-health-toronto","cat":"industry","name":"Homecoming (homecoming.health)","city":"Toronto","region":"Ontario","country":"Canada","cc":"CA","lat":43.71372,"lon":-79.3985,"gp":"city","layer":"tech","org_type":"patient-care / psychological-screening software","drugs":["ketamine","psilocybin"],"detail":"Owns the patient preparation/integration companion layer, now repositioned around automating validated psychological screening for psychedelic patients and making it billable to insurers (CPT 96130/96131, $500–$1,000/patient historical claims)","web":"https://www.homecoming.health/","people":"Yuriy Blokhin (founder & CEO); Dr. Brian Richards, PsyD (Clinical Director, ex-Johns Hopkins); Dr. Ben Kelmendi, MD (Lead Scientific Advisor, Yale)","src":"https://www.homecoming.health/","eid":"x:org:homecoming-homecoming-health-toronto"},{"id":"horizons-perspectives-on-psychedelics-horizons-media-inc-new-york-city","cat":"industry","name":"Horizons: Perspectives on Psychedelics (Horizons Media, Inc.)","city":"New York City","region":"New York","country":"United States","cc":"US","lat":40.72128,"lon":-74.01411,"gp":"city","layer":"association","org_type":"conference organizer (501(c)(3) educational charity)","detail":"Longest-running annual psychedelic conference (since 2007, 18 conferences); the New York gathering where research, policy, and industry audiences converge, incl. a dedicated industry/entrepreneurship day.","web":"https://horizonsconference.org/","people":"Kevin Balktick (Founder + Director); Julie Holland, MD (leadership); James Vasile, Esq. (leadership)","src":"https://horizonsconference.org/about","eid":"x:org:horizons-perspectives-on-psychedelics-horizons-media-inc-new-york-city"},{"id":"hunt-family-foundation-australia","cat":"industry","name":"Hunt Family Foundation","region":"VIC","country":"Australia","cc":"AU","lat":-38.0188,"lon":145.0234,"gp":"region","layer":"funder","org_type":"Private family foundation (philanthropy)","drugs":["psilocybin"],"detail":"Family foundation of Peter Hunt AM and Tania de Jong AM; its AUD$1M gift seeded Australia's largest philanthropic fund for psychedelic observational trials (via Mind Medicine Australia).","people":"Peter Hunt AM (Co-founder; ex-Greenhill Australia chairman); Tania de Jong AM (Co-founder)","src":"https://mugglehead.com/mind-medicine-australia-receives-aud1m-grant-for-psychedelic-research/","eid":"x:org:hunt-family-foundation-australia"},{"id":"innertrek-portland-us","cat":"industry","name":"InnerTrek","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52227,"lon":-122.68012,"gp":"city","kind":"training","drugs":["psilocybin"],"detail":"OHA-approved facilitator training program; formerly operated the InnerTrek Center for Psilocybin Services (licensed service center)","web":"https://innertrek.org","src":"https://innertrek.org/service-center/","layer":"Training programs","eid":"x:org:innertrek-portland-us"},{"id":"innertrek-llc-portland-hq-damascus-or-retreat-campus","cat":"industry","name":"InnerTrek LLC","city":"Portland (HQ); Damascus, OR retreat campus","region":"Oregon","country":"United States","cc":"US","lat":44.9112,"lon":-122.4091,"gp":"region","layer":"training","org_type":"Licensed facilitator training school + service center","drugs":["psilocybin"],"detail":"Oregon's marquee training school, founded by the Measure 109 architects; produced the first licensed US psilocybin facilitators.","web":"https://www.innertrek.org","people":"Tom Eckert (co-founder & program director; co-architect of Oregon Measure 109)","src":"https://www.innertrek.org/psychedelic-facilitator-training","eid":"x:org:innertrek-llc-portland-hq-damascus-or-retreat-campus"},{"id":"innerwell-new-york","cat":"industry","name":"Innerwell","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.7098,"lon":-74.01693,"gp":"city","layer":"tech","org_type":"psychedelic telehealth / digital psychiatry platform","drugs":["ketamine"],"detail":"Owns the insurance-accepting end of at-home ketamine/psychedelic telehealth: in-network with United, Anthem, Cigna, Aetna, BCBS across 40+ states — a differentiator vs. cash-pay peers","web":"https://www.helloinnerwell.com/","people":"Lisa Kennedy (co-founder & CEO); Anthony Mangia (co-founder, Head of Growth); Dr. Michael Cooper (co-founder, Medical Director); Lawrence Tucker, MD (Executive Medical Director, per site)","src":"https://www.helloinnerwell.com/","eid":"x:org:innerwell-new-york"},{"id":"integrative-psychiatry-institute-ipi-boulder-niwot-address-on-oha-list","cat":"industry","name":"Integrative Psychiatry Institute (IPI)","city":"Boulder (Niwot address on OHA list)","region":"Colorado","country":"United States","cc":"US","lat":40.00497,"lon":-105.26664,"gp":"city","layer":"training","org_type":"Private post-graduate psychedelic-therapy training institute","drugs":["psilocybin","ketamine","MDMA"],"detail":"Largest-scale US psychedelic-assisted therapy training provider; key credentialing pipeline for OR/CO facilitators and future FDA-era therapists.","web":"https://psychiatryinstitute.com","people":"Will Van Derveer, MD (co-founder, Medical Director); Keith Kurlander, MA, LPC (co-founder); Jaime Davila, MA, LPC (Director of Psychedelic Trainings); Rohini Kanniganti, MD (Physician Team Lead);…","src":"https://psychiatryinstitute.com/ipi-year-long-psychedelic-assisted-therapy-training/","eid":"x:org:integrative-psychiatry-institute-ipi-boulder-niwot-address-on-oha-list"},{"id":"international-society-for-research-on-psychedelics-isrp-usa","cat":"industry","name":"International Society for Research on Psychedelics (ISRP)","country":"United States","cc":"US","lat":38.5245,"lon":-77.407,"gp":"country","layer":"association","org_type":"scientific society / conference organizer","detail":"The academic society for psychedelic researchers; publishes the peer-reviewed journal Psychedelic Medicine and hosts the ISRP conference (next: Feb 27–Mar 1, 2026, Royal Sonesta, New Orleans).","email":"contact@isrpsych.org","web":"https://isrpsych.org/","people":"Peter Hendricks, PhD (Co-Editor, Psychedelic Medicine journal); Charles D. Nichols, PhD (Co-Editor, Psychedelic Medicine journal)","src":"https://isrpsych.org/","eid":"x:org:international-society-for-research-on-psychedelics-isrp-usa"},{"id":"iter-investments-fort-lauderdale","cat":"industry","name":"Iter Investments","city":"Fort Lauderdale","region":"Florida","country":"United States","cc":"US","lat":26.11087,"lon":-80.14587,"gp":"city","layer":"funder","org_type":"VC fund (psychedelic ecosystem)","detail":"Florida psychedelic VC (Fund I >$20M) with an unusually deep bench of clinical/regulatory/IP specialist leads; founder Dustin Robinson is a prominent industry lawyer-advocate.","web":"https://www.iterinvestments.com","people":"Dustin Robinson, Esq., CPA (Founder); Robert Velarde (Founder); Dr. Michelle Weiner, DO MPH (Clinical Lead); Dr. Scott Fisher, MD (Psychiatric Lead); Edgar Asebey, Esq. (FDA Lead); David Wood, Esq.,…","src":"https://www.iterinvestments.com/team","flag":true,"eid":"x:org:iter-investments-fort-lauderdale"},{"id":"jls-fund-new-york","cat":"industry","name":"JLS Fund","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.71554,"lon":-74.01684,"gp":"city","layer":"funder","org_type":"VC fund (neuromedicine/psychedelics)","detail":"NY psychedelics/precision-neuromedicine VC whose portfolio company Gilgamesh Pharmaceuticals was acquired by AbbVie in a deal worth up to $1.2B — the sector's marquee exit.","email":"info@jls.fund","web":"https://www.jls.fund","people":"Lindsay Hoover (Managing Partner); Simeon Schnapper (Managing Partner); Jeffrey Siegel (Partner & Investor Relations); Brendan Hussey (Principal); advisors incl. Leonard Pickard, Gul Dolen, Walter…","src":"https://www.jls.fund/team","eid":"x:org:jls-fund-new-york"},{"id":"joe-sandy-samberg-foundation-rye","cat":"industry","name":"Joe & Sandy Samberg Foundation","city":"Rye","region":"New York","country":"United States","cc":"US","lat":40.97514,"lon":-73.67776,"gp":"city","layer":"funder","org_type":"Private family foundation (philanthropy)","detail":"Family foundation prioritizing mental health incl. psychedelic-assisted modalities; co-funded (with Cohen Foundation) the $1M Penn Nursing-Columbia School of Social Work psychedelic-therapy training initiative.","web":"https://jssf.carrd.co","people":"Joe Samberg (Co-founder); Sandy Beeber Samberg, CPNP (Co-founder; pediatric nurse practitioner)","src":"https://jssf.carrd.co/","eid":"x:org:joe-sandy-samberg-foundation-rye"},{"id":"journey-clinical-new-york","cat":"industry","name":"Journey Clinical","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.70387,"lon":-74.00988,"gp":"city","layer":"tech","org_type":"KAP infrastructure platform / prescriber network","drugs":["ketamine"],"detail":"Owns the medical/prescribing layer for independent psychotherapists: decentralized-clinic model giving 2,500+ providers across 21 states access to KAP-trained prescribers, eligibility screening, dosing oversight and outcome monitoring","web":"https://www.journeyclinical.com/","people":"Jonathan Sabbagh (co-founder & Executive Chairman); Myriam Barthes (co-founder & CEO)","src":"https://www.journeyclinical.com/about-us","eid":"x:org:journey-clinical-new-york"},{"id":"joyous-foster-city","cat":"industry","name":"Joyous","city":"Foster City","region":"California","country":"United States","cc":"US","lat":37.55634,"lon":-122.27,"gp":"city","layer":"tech","org_type":"low-dose ketamine telehealth subscription","drugs":["ketamine"],"detail":"Owns the budget/microdose end of the at-home ketamine stack: $129/month subscription with daily text-based monitoring and AI-adjusted dosing, live in 28 states","phone":"(844) 774-0909","web":"https://www.joyous.team/","people":"Yossi Fishler (co-founder); Eyal Fishler (co-founder); Sharon Niv (co-founder, Chief of Customer Experience); Bobbi K. Leben (co-founder)","src":"https://www.joyous.team/","eid":"x:org:joyous-foster-city"},{"id":"latham-watkins-llp-washington","cat":"industry","name":"Latham & Watkins LLP","city":"Washington","region":"District of Columbia","country":"United States","cc":"US","lat":38.90222,"lon":-77.02729,"gp":"city","layer":"legal","org_type":"BigLaw firm (FDA regulatory practice publishing psychedelics alerts)","drugs":["psilocybin","ibogaine"],"detail":"Top-tier FDA regulatory practice tracking federal psychedelics policy for medical device, pharma, and biotech clients; its EO 14401 alert details FDA voucher issuance to psilocybin/methylone sponsors and ARPA-H state funding.","web":"https://www.lw.com/","people":"Jennifer L. Bragg (co-author, Washington DC; 'Trump Administration Shifts Policy to Accelerate Access to Psychedelic Drugs for Mental Illness', Apr 28 2026); Nathan A. Beaton (co-author, Washington…","src":"https://www.lw.com/en/insights/trump-administration-shifts-policy-to-accelerate-access-to-psychedelic-drugs-for-mental-illness","eid":"x:org:latham-watkins-llp-washington"},{"id":"luminaire-mushroom-company-portland","cat":"industry","name":"Luminaire Mushroom Company","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.53394,"lon":-122.67485,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer (sole proprietor)","drugs":["psilocybin"],"detail":"Small family-owned licensed manufacturer in the Oregon program","phone":"503-358-6138","email":"info@luminairemushroomcompany.com","web":"http://www.luminairemushroomcompany.com","people":"Alexander J. Romer (licensee/owner, per OHA directory listing)","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:luminaire-mushroom-company-portland"},{"id":"lykos-therapeutics-formerly-maps-pbc-san-jose","cat":"industry","name":"Lykos Therapeutics (formerly MAPS PBC)","city":"San Jose","region":"California","country":"United States","cc":"US","lat":37.32984,"lon":-121.89924,"gp":"city","layer":"training","org_type":"Pharmaceutical company operating the MDMA-AT therapist training program","drugs":["MDMA"],"detail":"Holder of the definitive MDMA-AT training curriculum; its regulatory timeline gates the entire MDMA therapist-training market.","web":"https://lykospbc.com","src":"https://www.ajmc.com/view/lykos-therapeutics-restructures-after-fda-setback-commits-to-progressing-mdma-therapy-for-ptsd","eid":"x:org:lykos-therapeutics-formerly-maps-pbc-san-jose"},{"id":"maps-multidisciplinary-association-for-psychedelic-studies-san-jose-2","cat":"industry","name":"MAPS (Multidisciplinary Association for Psychedelic Studies)","city":"San Jose","region":"California","country":"United States","cc":"US","lat":37.33021,"lon":-121.88691,"gp":"city","layer":"advocacy","org_type":"501(c)(3) nonprofit (policy, advocacy, education; research philanthropy)","drugs":["MDMA"],"detail":"The field's original advocacy institution (founded 1986); after spinning drug development into Lykos Therapeutics, MAPS doubled down as the movement-building/policy/education arm creating 'safe, legal, and equitable psychedelic access'","web":"https://maps.org","people":"Rick Doblin, PhD (Founder & President); Betty Aldworth (Co-Executive Director); Ismail Lourido Ali, JD (Co-Executive Director); Sia Henry, JD (Associate Director, Policy); Philippe Lucas, PhD…","src":"https://maps.org/organization/staff/","eid":"x:org:maps-multidisciplinary-association-for-psychedelic-studies-san-jose-2"},{"id":"maps-multidisciplinary-association-for-psychedelic-studies-policy-advocacy-san-j","cat":"industry","name":"MAPS (Multidisciplinary Association for Psychedelic Studies) — Policy & Advocacy","city":"San Jose","region":"California","country":"United States","cc":"US","lat":37.33539,"lon":-121.89303,"gp":"city","layer":"advocacy","org_type":"501(c)(3) nonprofit (psychedelic research & policy reform)","drugs":["MDMA","psilocybin"],"detail":"The longest-running psychedelics nonprofit's policy arm — drafts and drives nonpartisan psychedelic policy reform, published its Policy Guidebook (Feb 2026), and convenes the policy track at Psychedelic Science conferences.","web":"https://maps.org/","people":"Ismail Lourido Ali, J.D. (Co-Executive Director; former Director of Policy & Advocacy; founding co-chair, Psychedelic Bar Association; California-licensed attorney)","src":"https://maps.org/people/ismail-l-ali-jd/","eid":"x:org:maps-multidisciplinary-association-for-psychedelic-studies-policy-advocacy-san-j"},{"id":"maps-israel-il","cat":"industry","name":"MAPS Israel","country":"Israel","cc":"IL","lat":32.2259,"lon":35.0261,"gp":"country","kind":"training","drugs":["ketamine","MDMA","psilocybin"],"detail":"Nonprofit (reg. 516398716, founded 2021) developing psychedelic research and therapist-training programs for PTSD/TRD/eating disorders; partner on Sheba group-M","web":"https://www.maps-israel.org","people":"Adar Avnon MD (Clinical Manager), Lior Kritzman PhD (Head of Development & Knowledge), Daniella Wine AviTal (Admin Manager), Eyal Gura, board: Shiri Regev Messalem PhD, Prof. Mario Mikulincer; Keren…","src":"https://www.maps-israel.org/about-us","layer":"Training programs","eid":"x:org:maps-israel-il"},{"id":"mind-foundation-insight-conference-forum-berlin","cat":"industry","name":"MIND Foundation / INSIGHT Conference & Forum","city":"Berlin","region":"Berlin","country":"Germany","cc":"DE","lat":52.52225,"lon":13.40945,"gp":"city","layer":"association","org_type":"nonprofit (gGmbH) science organization / conference organizer","detail":"Organizes INSIGHT, the leading transdisciplinary European psychedelic research conference in Berlin, plus the recurring INSIGHT Forum public talk series; a hub for the German/EU professional ecosystem.","phone":"+49 30 2904 7658","email":"info@mind-foundation.org","web":"https://www.mind-foundation.org/insight-forum","people":"Dr. Henrik Jungaberle (CEO, MIND Foundation); Simon Reichersdörfer (Chair of Board of Trustees & INSIGHT Forum Director); Dr. Marvin Däumichen (Deputy Managing Director); Inna Krylovetska (Events…","src":"https://www.mind-foundation.org/insight-forum","eid":"x:org:mind-foundation-insight-conference-forum-berlin"},{"id":"mind-foundation-ggmbh-berlin-de","cat":"industry","name":"MIND Foundation gGmbH","city":"Berlin","region":"Berlin","country":"Germany","cc":"DE","lat":52.53345,"lon":13.40578,"gp":"city","kind":"training","drugs":["ketamine","psilocybin"],"detail":"Nonprofit European psychedelic research/education org: APT 15-month Augmented Psychotherapy Training for health professionals, Beyond Experience integration wor","phone":"+49 30 2904 7658","email":"info@mind-foundation.org","web":"https://www.mind-foundation.org","src":"https://www.mind-foundation.org/","layer":"Training programs","eid":"x:org:mind-foundation-ggmbh-berlin-de"},{"id":"magic-truffles-magictruffles-com-hazerswoude-dorp","cat":"industry","name":"Magic Truffles (magictruffles.com)","city":"Hazerswoude-Dorp","region":"South Holland","country":"Netherlands","cc":"NL","lat":51.9617,"lon":4.5217,"gp":"region","layer":"supplier","org_type":"Dutch magic truffle producer/retailer (address associated with Procare Handelsmaatschappij B.V., the major truffle grower)","detail":"Operating storefront at Noorddijk 3, Hazerswoude-Dorp - the address long associated with Procare, one of the two dominant Dutch truffle producers","phone":"+31 172-419449","email":"info@magictruffles.com","web":"https://www.magictruffles.com","src":"https://www.magictruffles.com/","eid":"x:org:magic-truffles-magictruffles-com-hazerswoude-dorp"},{"id":"mcguirewoods-llp-richmond","cat":"industry","name":"McGuireWoods LLP","city":"Richmond","region":"VA (authors across national offices)","country":"United States","cc":"US","lat":37.55644,"lon":-77.45814,"gp":"city","layer":"legal","org_type":"BigLaw firm (healthcare/pharma practice publishing psychedelics alerts)","drugs":["psilocybin","ibogaine"],"detail":"Serial psychedelics alert publisher (2023 psilocybin decriminalization, 2024 psilocybin mental-health, 2026 EO/DOJ) advising pharma, pharma-services, investors and health systems on decriminalization, treatment use and psychedelics investment.","web":"https://www.mcguirewoods.com/","people":"Craig B. Bleifer (co-author, 'Executive and DOJ Orders Accelerate Support for Psychedelic Therapies and Medical Marijuana', May 4 2026); Gregory E. Fosheim (co-author); Allyson M. Maur (co-author);…","src":"https://www.mcguirewoods.com/client-resources/alerts/2026/5/executive-and-doj-orders-accelerate-support-for-psychedelic-therapies-and-medical-marijuana/","eid":"x:org:mcguirewoods-llp-richmond"},{"id":"memoru-center-for-visionary-healing-arts-boulder","cat":"industry","name":"Memoru Center for Visionary Healing Arts","city":"Boulder","region":"Colorado","country":"United States","cc":"US","lat":40.00666,"lon":-105.2689,"gp":"city","layer":"training","org_type":"Psychedelic therapy center + practitioner training/mentorship","drugs":["psilocybin","MDMA"],"detail":"Brings MAPS Phase-3 MDMA trainer lineage directly into Colorado's licensed psilocybin training market.","email":"info@memoru.com","web":"https://memorucenter.org","people":"Sara Lewis, PhD, LCSW; Marcela Ot'alora G., MA, LPC; Bruce Poulter, RN, MPH (leadership team)","src":"https://memorucenter.org/","eid":"x:org:memoru-center-for-visionary-healing-arts-boulder"},{"id":"mind-medicine-australia-melbourne","cat":"industry","name":"Mind Medicine Australia","city":"Melbourne","region":"VIC","country":"Australia","cc":"AU","lat":-37.80313,"lon":144.97476,"gp":"city","layer":"funder","org_type":"Registered charity — funder, training provider & advocate","drugs":["psilocybin"],"detail":"Australia's central psychedelic-therapy charity — funds observational trials and patient access, trains therapists, and drove the world-first TGA rescheduling of psilocybin and MDMA (2023).","phone":"+61 3 8679 6015","email":"hello@mindmedicineaustralia.org","web":"https://mindmedicineaustralia.org.au","people":"Peter Hunt AM (Chair & Co-founder); Tania de Jong AM (Deputy Chair & Executive Director, Co-founder); Hon Andrew Robb AO (Director); Nicholas Smedley (Director); Monojit Ray (Director); Trudi…","src":"https://mindmedicineaustralia.org.au/board/","eid":"x:org:mind-medicine-australia-melbourne"},{"id":"mind-medicine-australia-cpat-program-melbourne","cat":"industry","name":"Mind Medicine Australia (CPAT program)","city":"Melbourne","region":"Victoria","country":"Australia","cc":"AU","lat":-37.80379,"lon":144.96751,"gp":"city","layer":"training","org_type":"Registered charity running Certificate in Psychedelic-Assisted Therapies","drugs":["psilocybin","MDMA"],"detail":"The dominant practitioner-training program for the world's first national legal psilocybin/MDMA prescribing regime.","phone":"+61 3 8679 6015","web":"https://mindmedicineaustralia.org.au","people":"Dr Eli Kotler (Australian Director, CPAT)","src":"https://mindmedicineaustralia.org.au/certificate-in-psychedelic-assisted-therapies-cpat/","eid":"x:org:mind-medicine-australia-cpat-program-melbourne"},{"id":"mindbloom-new-york","cat":"industry","name":"Mindbloom","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.70359,"lon":-74.00715,"gp":"city","layer":"tech","org_type":"at-home ketamine telehealth platform","drugs":["ketamine"],"detail":"Owns the largest consumer at-home ketamine vertical: clinician-prescribed guided programs (200,000+ sessions to date) with integration coaching and peer monitoring; category survivor while competitors closed","web":"https://www.mindbloom.com/","people":"Dylan Beynon (founder & CEO)","src":"https://www.mindbloom.com/","eid":"x:org:mindbloom-new-york"},{"id":"ministry-of-health-of-the-czech-republic-ministerstvo-zdravotnictvi-cr-medical-p","cat":"industry","name":"Ministry of Health of the Czech Republic (Ministerstvo zdravotnictví ČR) — Medical Psilocybin Framework","city":"Prague","region":"Prague","country":"Czechia","cc":"CZ","lat":50.08329,"lon":14.42212,"gp":"city","layer":"regulator","org_type":"national health ministry (medical psilocybin authorization)","drugs":["psilocybin"],"detail":"First EU member state to regulate medical psilocybin: law signed July 17, 2025, effective Jan 1, 2026; the Ministry authorizes the treating facilities and approves training programs (with the Czech Neuropharmacological Society); NUDZ expects treatment launch…","phone":"+420 224 971 111","email":"mzcr@mzcr.cz","web":"https://mzd.gov.cz/","src":"https://dostupnyadvokat.cz/en/blog/therapeutic-use-of-psilocybin-new-legal-framework-from-2026","eid":"x:org:ministry-of-health-of-the-czech-republic-ministerstvo-zdravotnictvi-cr-medical-p"},{"id":"mondo-grow-kits-mgk-logistics-b-v-purmerend","cat":"industry","name":"Mondo Grow Kits (MGK Logistics B.V.)","city":"Purmerend","region":"North Holland","country":"Netherlands","cc":"NL","lat":52.49865,"lon":4.95572,"gp":"city","layer":"supplier","org_type":"Dutch magic truffle & mushroom grow kit producer/wholesaler","drugs":["psilocybin"],"detail":"Established legal NL producer-distributor shipping truffles and kits B2C/B2B across the EU and UK","phone":"+31 6 28323329","email":"info@mondogrowkits.com","web":"https://www.mondogrowkits.com","src":"https://www.mondogrowkits.com/","eid":"x:org:mondo-grow-kits-mgk-logistics-b-v-purmerend"},{"id":"morgan-lewis-bockius-llp-washington","cat":"industry","name":"Morgan Lewis & Bockius LLP","city":"Washington","region":"DC (firm HQ Philadelphia, PA)","country":"United States","cc":"US","lat":38.89111,"lon":-77.04762,"gp":"city","layer":"legal","org_type":"BigLaw firm (FDA/life sciences practice publishing psychedelics alerts)","drugs":["psilocybin","MDMA","ketamine"],"detail":"2,200-lawyer firm whose FDA/life-sciences partners publish sustained psychedelics analysis (2024 symposium blog, 2025 DEA actions, 2026 EO alert) covering trial design, DEA registration, and state controlled-substance law for sponsors.","web":"https://www.morganlewis.com/","people":"Jacqueline R. Berman (Partner, Washington DC; co-author 'You Are Not Hallucinating: Executive Order Aims to Accelerate Approval of Therapeutic Psychedelics', Apr 28 2026); Michele L. Buenafe…","src":"https://www.morganlewis.com/pubs/2026/04/you-are-not-hallucinating-executive-order-aims-to-accelerate-approval-of-therapeutic-psychedelics","eid":"x:org:morgan-lewis-bockius-llp-washington"},{"id":"murata-vios-vios-medical-usa","cat":"industry","name":"Murata Vios (Vios Medical)","country":"United States","cc":"US","lat":38.5481,"lon":-77.0932,"gp":"country","layer":"tech","org_type":"wireless patient-monitoring platform (Murata subsidiary)","drugs":["ketamine"],"detail":"Owns multi-patient wireless telemetry for dosing environments: FDA-cleared Vios Monitoring System (7-lead ECG, HR, SpO2, respiration, posture) with 24/7 remote monitoring services; company's own site names ketamine clinics as a target market alongside rehab…","web":"https://www.viosmedical.com/","people":"Amit Patel (co-founder & CEO; ex-HeartFlow, ex-Medtronic corporate development)","src":"https://www.viosmedical.com/about-us/","eid":"x:org:murata-vios-vios-medical-usa"},{"id":"mush-to-do-llc-usa","cat":"industry","name":"Mush To Do, LLC","region":"Oregon","country":"United States","cc":"US","lat":44.6861,"lon":-122.5326,"gp":"region","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer","detail":"Licensed Oregon psilocybin manufacturer listed in the state's voluntary directory","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:mush-to-do-llc-usa"},{"id":"mystic-ventures-los-angeles","cat":"industry","name":"Mystic Ventures","city":"Los Angeles","region":"California","country":"United States","cc":"US","lat":34.04672,"lon":-118.23479,"gp":"city","layer":"funder","org_type":"VC rolling fund (pre-seed/seed biotech)","detail":"AngelList rolling fund for psychedelic medicine and 'consciousness expansion' startups, notable for crypto-native GPs Jeremy Gardner and Brock Pierce.","web":"https://www.mystic.ventures","people":"Jeremy Gardner (Founder & Managing Partner); Brock Pierce (General Partner, joined 2022 per Benzinga)","src":"https://www.mystic.ventures/","eid":"x:org:mystic-ventures-los-angeles"},{"id":"naitur-successor-venture-to-maya-health-denver","cat":"industry","name":"Naitur (successor venture to Maya Health)","city":"Denver","region":"Colorado","country":"United States","cc":"US","lat":39.74042,"lon":-104.98277,"gp":"city","layer":"tech","org_type":"practice AI/automation services","drugs":["ketamine"],"detail":"Answers the 'Maya Health status' question: mayahealth.com now 301-redirects to naitur.ai — the standalone Maya psychedelic data/outcomes platform is no longer operating; Champion's current company builds custom AI automation (intake-to-EMR sync, scale…","web":"https://naitur.ai/","people":"David Champion (founder & CEO; previously founder & CEO of Maya Health, co-founder Baker Technologies and Unlimited Sciences)","src":"https://naitur.ai/","eid":"x:org:naitur-successor-venture-to-maya-health-denver"},{"id":"naropa-university-center-for-psychedelic-studies-boulder","cat":"industry","name":"Naropa University - Center for Psychedelic Studies","city":"Boulder","region":"Colorado","country":"United States","cc":"US","lat":40.0268,"lon":-105.26824,"gp":"city","layer":"training","org_type":"University certificate programs (contemplative university)","drugs":["psilocybin","MDMA"],"detail":"Flagship contemplative-university entrant lending academic legitimacy; equity-focused facilitator training in Colorado's home market.","phone":"1-800-772-6951","email":"psychedelicstudies@naropa.edu","web":"https://www.naropa.edu/academics/schools-centers/center-for-psychedelic-studies/","people":"Joseph Harrison, MS (Executive Director, Naropa Center for Psychedelic Studies); Diana Quinn, ND (Director, Psilocybin Facilitator Training)","src":"https://www.naropa.edu/academics/schools-centers/center-for-psychedelic-studies/psilocybin-facilitator-training-certificate-program/","eid":"x:org:naropa-university-center-for-psychedelic-studies-boulder"},{"id":"negev-capital-tel-aviv","cat":"industry","name":"Negev Capital","city":"Tel Aviv","country":"Israel","cc":"IL","lat":32.0734,"lon":34.76989,"gp":"city","layer":"funder","org_type":"VC fund (CNS/psychedelic drug development)","detail":"$30M+ seed/Series A fund fully invested across 27 psychedelic drug-development companies, with validated exits to AbbVie (Gilgamesh) and Otsuka.","email":"lp@negevcap.com; bd@negevcap.com; founders@negevcap.com","web":"https://negevcap.com","people":"Ken Belotsky (Co-Founding Partner, Vienna); Vadim Uzberg (Co-Founder & Managing Director, Limassol); Dr. Stuart Seidman (Partner, Medical Science Lead, New York); Prof. Bernard Lerer (Chief of…","src":"https://negevcap.com/","eid":"x:org:negev-capital-tel-aviv"},{"id":"new-mexico-medical-psilocybin-program-nm-department-of-health-santa-fe","cat":"industry","name":"New Mexico Medical Psilocybin Program (NM Department of Health)","city":"Santa Fe","region":"New Mexico","country":"United States","cc":"US","lat":35.69503,"lon":-105.94905,"gp":"city","layer":"regulator","org_type":"state program office (Center for Medical Cannabis and Psilocybin)","drugs":["psilocybin"],"detail":"First state medical-model psilocybin program (SB 219, signed April 2025, effective June 20, 2025); DOH is in rulemaking with full implementation targeted Dec 31, 2026 — the next major state market to open.","phone":"505-827-2321","email":"medical.psilocybin@doh.nm.gov","web":"https://www.nmhealth.org/about/mcpp/mpp/","src":"https://www.nmhealth.org/about/mcpp/mpp/","eid":"x:org:new-mexico-medical-psilocybin-program-nm-department-of-health-santa-fe"},{"id":"no-fallen-heroes-foundation-boca-raton","cat":"industry","name":"No Fallen Heroes Foundation","city":"Boca Raton","region":"Florida","country":"United States","cc":"US","lat":26.36391,"lon":-80.08362,"gp":"city","layer":"funder","org_type":"501(c)(3) nonprofit (retreat grants for veterans/first responders)","drugs":["psilocybin"],"detail":"Fully funds entheogenic healing retreats and healing grants for veterans, first responders, and family members; suicide-prevention framing gives the field mainstream political cover","web":"https://nofallenheroesfoundation.org","people":"Matthew 'Whiz' Buckley (Founder & President); Suzi Buckley (Executive Director); Linda Provan (Board Secretary & Grants Director)","src":"https://nofallenheroesfoundation.org/about-us/","eid":"x:org:no-fallen-heroes-foundation-boca-raton"},{"id":"noetic-fund-toronto","cat":"industry","name":"Noetic Fund","city":"Toronto","region":"ON","country":"Canada","cc":"CA","lat":43.70619,"lon":-79.39812,"gp":"city","layer":"funder","org_type":"VC fund (psychedelic/CNS early stage)","detail":"Toronto psychedelic VC with 25+ portfolio companies and exits in COMPASS Pathways, Cybin, and Numinus; led the $7.2M seed for the Alexander Shulgin Research Institute.","web":"https://noeticfund.com","people":"Sa'ad Shah (Managing Partner & Co-founder); Warren Wright (Managing Partner); Michael Franks (Co-founder, per launch press); Sri Teja Mullapudi, PhD (Principal, Fund Investments & Scientific Lead);…","src":"https://noeticfund.com/","eid":"x:org:noetic-fund-toronto"},{"id":"nordic-analytical-laboratories-denver-and-pueblo","cat":"industry","name":"Nordic Analytical Laboratories","city":"Denver and Pueblo","region":"Colorado","country":"United States","cc":"US","lat":39.8708,"lon":-105.2787,"gp":"region","layer":"supplier","org_type":"Colorado NMD-licensed natural medicine testing facility (first licensed, May 2025)","drugs":["psilocybin"],"detail":"Its licensure completed Colorado's regulated psilocybin supply chain - every product must pass through it (sole licensed lab at launch)","web":"https://nordiclabs.com","src":"https://psychedelicalpha.com/news/colorados-psilocybin-supply-chain-complete-first-testing-lab-licensed-sessions-could-begin-this-month/","eid":"x:org:nordic-analytical-laboratories-denver-and-pueblo"},{"id":"noveris-health-sciences-fka-mydecine-innovations-group-denver-historic-mydecine-","cat":"industry","name":"Noveris Health Sciences (fka Mydecine Innovations Group)","city":"Denver (historic Mydecine HQ; post-restructuring base unconfirmed)","region":"Colorado","country":"United States","cc":"US","lat":39.74023,"lon":-104.97985,"gp":"city","layer":"developer","org_type":"pharma (micro-cap, preclinical; CSE: NVRS)","drugs":["psilocybin"],"detail":"Survivor-in-name-only of the 2020-21 psychedelic wave: restructured, renamed, preclinical assets in smoking cessation and PTSD.","people":"Jason Birmingham (President, CEO & Director since Mar 2026; previously Chief Strategy Officer); Joshua Bartch (former CEO, resigned Mar 10, 2026)","src":"https://www.newsfilecorp.com/release/282389/CSE-Bulletin-Name-and-Symbol-Change-Mydecine-Innovations-Group-Inc.-MYCO","eid":"x:org:noveris-health-sciences-fka-mydecine-innovations-group-denver-historic-mydecine-"},{"id":"nue-life-health-nueco-holdings-pbc-defunct-miami","cat":"industry","name":"Nue Life Health (NueCo Holdings PBC) — DEFUNCT","city":"Miami","region":"Florida","country":"United States","cc":"US","lat":25.76566,"lon":-80.19258,"gp":"city","layer":"tech","org_type":"at-home ketamine telehealth (wound down)","drugs":["ketamine"],"detail":"Status answer for a once-major at-home ketamine platform: after $3.3M seed (2021) + $23M Series A led by Obvious Ventures (2022), it struggled, was acquired by venture studio Beckley Waves via NueCo Holdings PBC (Oct 2023), and the consumer program has since…","web":"https://psychedelicalpha.com/news/p%CE%B1-a-nue-lease-of-life-beckley-waves-acquires-struggling-at-home-ketamine-provider-nue-life-health","people":"Juan Pablo Cappello (co-founder & CEO); Demian Bellumio (co-founder)","src":"https://psychedelicalpha.com/news/p%CE%B1-a-nue-lease-of-life-beckley-waves-acquires-struggling-at-home-ketamine-provider-nue-life-health","eid":"x:org:nue-life-health-nueco-holdings-pbc-defunct-miami"},{"id":"numinus-numinus-network-training-division-vancouver","cat":"industry","name":"Numinus (Numinus Network - training division)","city":"Vancouver","region":"British Columbia (HQ); Murray, UT on OHA list","country":"Canada","cc":"CA","lat":49.25959,"lon":-123.12654,"gp":"city","layer":"training","org_type":"For-profit mental-health company's PAT training arm","drugs":["psilocybin","MDMA","ketamine"],"detail":"Only cross-border (US/Canada) training operator approved in both Oregon and Colorado; ties training to a clinic network.","phone":"1-833-686-4687","email":"training@numinusnetwork.com","web":"https://numinusnetwork.com/training","people":"Hannah Cross, LCSW (course facilitator); Stephen Thayer, PhD (psychologist/instructor); Deanna Rogers, MA (instructor & subject-matter expert)","src":"https://numinusnetwork.com/training/oregon-approved-psilocybin-assisted-therapy-pathway/","eid":"x:org:numinus-numinus-network-training-division-vancouver"},{"id":"numinus-wellness-numinus-network-vancouver-ca","cat":"industry","name":"Numinus Wellness / Numinus Network","city":"Vancouver","region":"BC","country":"Canada","cc":"CA","lat":49.26025,"lon":-123.12447,"gp":"city","kind":"training","drugs":["ketamine","MDMA","psilocybin"],"detail":"Post-restructuring: asset-light provider of board-accredited psychedelic-assisted therapy training for licensed/non-licensed providers, clinical trials support,","phone":"1-833-686-4687","email":"training@numinusnetwork.com","web":"https://numinusnetwork.com/","src":"https://numinusnetwork.com/","layer":"Training programs","eid":"x:org:numinus-wellness-numinus-network-vancouver-ca"},{"id":"optimi-health-corp-princeton","cat":"industry","name":"Optimi Health Corp.","city":"Princeton","region":"British Columbia","country":"Canada","cc":"CA","lat":49.44724,"lon":-120.50714,"gp":"city","layer":"supplier","org_type":"commercial-stage GMP psilocybin & MDMA manufacturer (Drug Establishment Licence + dealer's licence)","drugs":["psilocybin","MDMA"],"detail":"Canada's largest GMP-grade licensed psilocybin cultivation facility; exports finished-dose psilocybin and MDMA to Australia's authorized prescribers (PTSD/TRD) and supplies trials (e.g., Psyence Biomed Phase IIb)","email":"ir@optimi.net","web":"https://www.optimi.net","people":"Dane Stevens (co-founder & CEO); JJ Wilson (co-founder); Jacob Safarik (CFO); Dr. Preston Chase (Chief Science Officer); Robert Martin (Chief Strategy Officer)","src":"https://www.optimi.net/","eid":"x:org:optimi-health-corp-princeton"},{"id":"oregon-psilocybin-services-oregon-health-authority-portland","cat":"industry","name":"Oregon Psilocybin Services (Oregon Health Authority)","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.51945,"lon":-122.67899,"gp":"city","layer":"regulator","org_type":"state program office (OHA Public Health Division, Center for Health Protection)","drugs":["psilocybin"],"detail":"First-in-nation regulator (Measure 109, 2020): licenses psilocybin manufacturers, service centers, facilitators, labs, and transport; licensing opened Jan 2, 2023 — the template every supplier/training program in the state operates under.","phone":"971-673-0322","email":"OHA.Psilocybin@oha.oregon.gov","web":"https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Oregon-Psilocybin-Services.aspx","people":"Angela (Angie) Allbee (Section Manager, Oregon Psilocybin Services)","src":"https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Psilocybin-Contact-Us.aspx","eid":"x:org:oregon-psilocybin-services-oregon-health-authority-portland"},{"id":"oregon-psychedelic-institute-joseph","cat":"industry","name":"Oregon Psychedelic Institute","city":"Joseph","region":"Oregon","country":"United States","cc":"US","lat":45.34844,"lon":-117.22457,"gp":"city","layer":"training","org_type":"Facilitator training program","drugs":["psilocybin"],"detail":"Rural eastern-Oregon curriculum holder.","web":"http://www.oregonpsych.com","src":"https://psilocybin.oregon.gov/training-approved","eid":"x:org:oregon-psychedelic-institute-joseph"},{"id":"osmind-san-francisco","cat":"industry","name":"Osmind","city":"San Francisco","region":"California","country":"United States","cc":"US","lat":37.77422,"lon":-122.41344,"gp":"city","layer":"tech","org_type":"EHR / practice-management software (public benefit corp)","drugs":["ketamine","esketamine"],"detail":"Owns the system-of-record layer: dominant EHR + billing/RCM for interventional psychiatry (1,000+ practices, 1M+ treatments); only private-practice EHR with automated Spravato REMS form submission; AI scribe; Caretaker Medical vitals integration","web":"https://www.osmind.org/","people":"Lucia Huang (co-founder & CEO); Jimmy Qian (co-founder & COO); Will Sauvé, MD (Chief Medical Officer, per site)","src":"https://www.osmind.org/","eid":"x:org:osmind-san-francisco"},{"id":"palo-santo-chicago","cat":"industry","name":"Palo Santo","city":"Chicago","region":"Illinois","country":"United States","cc":"US","lat":41.8561,"lon":-87.64445,"gp":"city","layer":"funder","org_type":"VC fund (psychedelic therapeutics)","drugs":["psilocybin","MDMA"],"detail":"One of the largest dedicated psychedelic-therapeutics VC funds; $50M fund backing 20+ companies across the drug-development ecosystem.","web":"https://palosanto.vc","people":"Daniel Goldberg (Founder & Partner); Edny Inui, Ph.D. (Partner); Tony Eisenberg (Co-founder & Venture Partner); Tim Schlidt (Co-founder, per 2021 launch press); Adrienne Jo, Ph.D. (Principal); Ailsa…","src":"https://palosanto.vc/team","eid":"x:org:palo-santo-chicago"},{"id":"perkins-coie-llp-now-ashurst-perkins-coie-seattle","cat":"industry","name":"Perkins Coie LLP (now Ashurst Perkins Coie)","city":"Seattle","region":"WA (national; Oregon/DC involvement in psilocybin matters)","country":"United States","cc":"US","lat":47.60061,"lon":-122.33598,"gp":"city","layer":"legal","org_type":"BigLaw firm (cannabis/psychedelics counsel; DEA psilocybin rescheduling litigation)","drugs":["psilocybin"],"detail":"Represents Dr. Sunil Aggarwal/AIMS in the landmark Ninth Circuit litigation challenging DEA's refusal to reschedule psilocybin (petition granted and remanded to DEA, Feb 2025), alongside its state-program client updates.","web":"https://www.ashurstperkinscoie.com/","people":"Andrew Kline (co-author, 'Psilocybin: Updates in Oregon and Around the Country', Jul 14 2023); Holly Martinez (co-author); Thomas Tobin (co-author)","src":"https://www.jdsupra.com/legalnews/psilocybin-updates-in-oregon-and-around-8487359/","eid":"x:org:perkins-coie-llp-now-ashurst-perkins-coie-seattle"},{"id":"pharmala-biotech-holdings-ltd-toronto","cat":"industry","name":"PharmAla Biotech Holdings Ltd.","city":"Toronto","region":"Ontario","country":"Canada","cc":"CA","lat":43.70356,"lon":-79.40546,"gp":"city","layer":"supplier","org_type":"MDMA (clinical-grade) developer/supplier via licensed partner labs; TSXV-listed","drugs":["MDMA"],"detail":"Principal commercial supplier of clinical-grade LaNeo MDMA to researchers and to Australia's Authorised Prescriber pathway","phone":"1-855-444-6362","email":"outreach@pharmala.ca","web":"https://pharmala.ca","people":"Nicholas Kadysh (founding CEO & President); Jodi Butts (Board Chair); Will Avery (CFO); Harpreet Kaur (VP Research)","src":"https://pharmala.ca/","eid":"x:org:pharmala-biotech-holdings-ltd-toronto"},{"id":"polaris-insight-center-san-francisco","cat":"industry","name":"Polaris Insight Center","city":"San Francisco","region":"California","country":"United States","cc":"US","lat":37.76829,"lon":-122.4126,"gp":"city","layer":"training","org_type":"KAP clinic and training center","drugs":["ketamine"],"detail":"Leading independent KAP training lineage - the currently-legal molecule where practitioner demand is real today.","phone":"415-800-7083","email":"training@polarisinsight.com","web":"https://www.polarisinsight.com","people":"Veronika Gold, LMFT (co-founder, trainer & consultant); Eric Sienknecht, PsyD (lead trainer); approved consultants incl. Harvey Schwartz, PhD; Evan Sola, PsyD","src":"https://www.polarisinsight.com/certificate-program/","eid":"x:org:polaris-insight-center-san-francisco"},{"id":"psilera-tampa","cat":"industry","name":"Psilera","city":"Tampa","region":"Florida","country":"United States","cc":"US","lat":27.95425,"lon":-82.46243,"gp":"city","layer":"developer","org_type":"pharma (private, preclinical)","detail":"Preclinical neuroplastogen shop targeting behavioral-variant frontotemporal dementia (bvFTD) — a rare non-psychiatric psychedelic indication.","email":"info@psilera.com","web":"https://www.psilera.com","people":"Chris Witowski, PhD (Co-founder & CEO); Jackie von Salm, PhD (Co-founder & CSO); Magali Haas, MD, PhD (Chief Medical Officer); Scott Rairigh (EVP Corporate Development); Allyson Gage, PhD (VP…","src":"https://www.prnewswire.com/news-releases/psilera-closes-oversubscribed-8-8m-seed-funding-round-to-accelerate-neuroplastogen-psil-006-into-the-clinic-302784223.html","eid":"x:org:psilera-tampa"},{"id":"psilo-scientific-ltd-metro-vancouver-burnaby","cat":"industry","name":"Psilo Scientific Ltd.","city":"Metro Vancouver (Burnaby)","region":"British Columbia","country":"Canada","cc":"CA","lat":49.4377,"lon":-122.7531,"gp":"region","layer":"supplier","org_type":"licensed dealer / botanical psychedelic extraction subsidiary (of Filament Health)","drugs":["psilocybin"],"detail":"Health Canada-licensed extraction arm that completed the industry-first export of natural GMP psilocybin to UCSF for a Phase 1 FDA trial","web":"https://filament.health","people":"Benjamin Lightburn (CEO of parent Filament Health)","src":"https://www.filament.health/news/filament-health-successfully-completes-industry-first-export-of-natural-gmp-psychedelics-to-the-united-states-through-its-wholly-owned-subsidiary-psilo-scientific-ltd","eid":"x:org:psilo-scientific-ltd-metro-vancouver-burnaby"},{"id":"psymed-ventures-san-francisco","cat":"industry","name":"PsyMed Ventures","city":"San Francisco","region":"California","country":"United States","cc":"US","lat":37.77968,"lon":-122.42474,"gp":"city","layer":"funder","org_type":"VC fund (frontier brain & mental health)","drugs":["ketamine"],"detail":"$25M early-stage fund at the psychedelics/neurotech/precision-psychiatry intersection; 30+ investments and an influential industry podcast (Business Trip).","email":"hi@psymed.ventures","web":"https://psymed.ventures","people":"Matias Serebrinsky (General Partner & Co-founder); Greg Kubin (General Partner & Co-founder); Dina Burkitbayeva (Co-founder; CEO of portfolio co Freedom Biosciences); Danny Carbonero, PhD…","src":"https://psymed.ventures/","eid":"x:org:psymed-ventures-san-francisco"},{"id":"psyche-insights-usa-israel","cat":"industry","name":"Psyche Insights","country":"United States","cc":"US","lat":38.7167,"lon":-76.8658,"gp":"country","layer":"tech","org_type":"clinic management software (all-in-one platform)","drugs":["ketamine"],"detail":"Owns the all-in-one clinic OS niche for KAP/psychedelic clinics: intake-to-integration workflow with built-in AI clinical scribe, 12+ validated scales (PHQ-9, GAD-7, CADSS, 5D-ASC), telehealth, scheduling, billing; US + Israel compliance modes, Hebrew/Arabic…","web":"https://app.psycheinsights.com/","people":"Founders not published on site (see coverage notes)","src":"https://app.psycheinsights.com/","eid":"x:org:psyche-insights-usa-israel"},{"id":"psychedelic-bar-association-usa","cat":"industry","name":"Psychedelic Bar Association","country":"United States","cc":"US","lat":38.399,"lon":-76.9207,"gp":"country","layer":"legal","org_type":"Professional society / bar association for psychedelics lawyers","drugs":["psilocybin","MDMA","ketamine"],"detail":"The organizing hub of the psychedelics bar — connects attorneys across regulatory, IP, religious-freedom, and litigation issues; its board doubles as a directory of the sector's leading boutique firms.","web":"https://thepsychedelicbar.org/","people":"Madalyn McElwain (Interim Executive Director; co-chair, Legalization & Regulation Committee); Sherrie McCumber (Director of Operations); Christian Holden (Board Chair; co-founder, Holden & Kelly Law…","src":"https://thepsychedelicbar.org/board/","eid":"x:org:psychedelic-bar-association-usa"},{"id":"psychedelic-bar-association-pba-usa","cat":"industry","name":"Psychedelic Bar Association (PBA)","region":"Washington (fiscal sponsor CascadiaNow!, Seattle)","country":"United States","cc":"US","lat":38.8304,"lon":-76.6266,"gp":"country","layer":"association","org_type":"legal professional association (fiscally sponsored nonprofit)","drugs":["psilocybin","MDMA","ketamine"],"detail":"The bar association for attorneys practicing psychedelic law — the connective tissue between operators, regulators, and legal counsel; member directory is a channel to the field's specialist lawyers.","web":"https://thepsychedelicbar.org/","people":"Christian Holden (Board Chair); Madalyn McElwain (Interim Executive Director); Sherrie McCumber (Director of Operations); Jon Dennis (Board Member); Laurel Kilgour (Board Member); Jodi Green (Board…","src":"https://thepsychedelicbar.org/board/","eid":"x:org:psychedelic-bar-association-pba-usa"},{"id":"psychedelic-medicine-association-pma-usa","cat":"industry","name":"Psychedelic Medicine Association (PMA)","country":"United States","cc":"US","lat":38.7833,"lon":-77.1207,"gp":"country","layer":"association","org_type":"professional association (public benefit corporation)","drugs":["psilocybin","ketamine","MDMA"],"detail":"Member-dues-funded association educating frontline physicians/therapists on psychedelic therapies and pushing for payer coverage; founding members included Field Trip and Numinus; runs the Psychedelic Medicine Podcast.","web":"https://www.psychedelicmedicineassociation.org/","people":"Lynn Marie Morski, MD, JD (Founder and President); Barney Neal (Chief Technology Officer)","src":"https://psychedelicalpha.com/news/lynn-marie-morski-psychedelic-medicine-association/","eid":"x:org:psychedelic-medicine-association-pma-usa"},{"id":"psychedelic-science-maps-denver","cat":"industry","name":"Psychedelic Science (MAPS)","city":"Denver","region":"Colorado (next event)","country":"United States","cc":"US","lat":39.74823,"lon":-104.97486,"gp":"city","layer":"association","org_type":"conference organizer (nonprofit-produced industry/science conference)","drugs":["MDMA","psilocybin"],"detail":"The field's largest conference (8,000+ expected), produced by the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2010; next edition May 3–7, 2027 at the Colorado Convention Center, theme 'Bridging Promise & Practice'.","web":"https://psychedelicscience.org/","src":"https://psychedelicscience.org/","eid":"x:org:psychedelic-science-maps-denver"},{"id":"psychedelic-science-funders-collaborative-psfc-usa","cat":"industry","name":"Psychedelic Science Funders Collaborative (PSFC)","country":"United States","cc":"US","lat":38.5716,"lon":-77.1481,"gp":"country","layer":"funder","org_type":"Philanthropic funders collaborative, 501(c)(3)","drugs":["MDMA","psilocybin"],"detail":"The coordinating hub for psychedelic philanthropy — pools/aligns member donors' giving on research, policy, and healthcare integration (organized MAPS's $30M Capstone Challenge for MDMA Phase 3).","web":"https://psfc.co","people":"Graham Boyd (Co-founder & Executive Director); Joe Green (Co-founder & President); Ben Collins (Director of Programs and Partnerships); Board: Joe Green, Graham Boyd, Protik Basu, David Bronner,…","src":"https://psfc.co/","eid":"x:org:psychedelic-science-funders-collaborative-psfc-usa"},{"id":"psychedelic-training-centre-nz-nz","cat":"industry","name":"Psychedelic Training Centre NZ","country":"New Zealand","cc":"NZ","lat":-41.6376,"lon":174.4207,"gp":"country","kind":"training","drugs":["psilocybin"],"detail":"Certificate in Psychedelic-Assisted Therapies (CPAT): four-month hybrid programme for psychiatrists, psychologists, social workers and other healthcare professi","email":"info@psytrain.co.nz","web":"https://psytrain.co.nz","src":"https://psytrain.co.nz/","layer":"Training programs","eid":"x:org:psychedelic-training-centre-nz-nz"},{"id":"psygen-industries-ltd-calgary","cat":"industry","name":"Psygen Industries Ltd.","city":"Calgary","region":"Alberta","country":"Canada","cc":"CA","lat":51.04762,"lon":-114.08609,"gp":"city","layer":"supplier","org_type":"GMP psychedelic API contract manufacturer (CMO); Health Canada dealer's licence","drugs":["LSD","MDMA","psilocybin","DMT","mescaline"],"detail":"Purpose-built 17,000 sq ft GMP psychedelic API facility; has exported LSD to New Zealand and completed an MDMA development program","web":"https://psygen.ca","people":"Danny Motyka (co-founder & CEO); Peter van der Heyden (co-founder & Chief Science Officer)","src":"https://psygen.ca/","eid":"x:org:psygen-industries-ltd-calgary"},{"id":"quantified-citizen-vancouver","cat":"industry","name":"Quantified Citizen","city":"Vancouver","region":"British Columbia","country":"Canada","cc":"CA","lat":49.26147,"lon":-123.11534,"gp":"city","layer":"tech","org_type":"mobile decentralized-research platform","drugs":["psilocybin"],"detail":"Owns mobile research/data-collection infrastructure for psychedelic science: built Microdose.me with Paul Stamets (19,000+ participants; Nature Scientific Reports publications) and was contracted by University of Washington to implement protocol/data…","web":"https://quantifiedcitizen.com/","people":"Eesmyal Santos-Brault (co-founder & CEO); Kalin Harvey (co-founder & CTO)","src":"https://quantifiedcitizen.com/","eid":"x:org:quantified-citizen-vancouver"},{"id":"reason-foundation-psychedelics-policy-project-los-angeles","cat":"industry","name":"Reason Foundation — Psychedelics Policy Project","city":"Los Angeles","region":"CA (also Washington, DC office)","country":"United States","cc":"US","lat":34.05134,"lon":-118.24147,"gp":"city","layer":"advocacy","org_type":"Think tank (free-market policy research)","drugs":["psilocybin"],"detail":"Not thin after all: runs a recurring Psychedelics Policy Newsletter, multiple policy briefs (personal psychedelics license framework, psilocybin modernization), and a Psychedelics Policy Reform Impact Tracker (psychedelicdata.reason.org) used in state debates.","phone":"(310) 391-2245","web":"https://reason.org/psychedelics-policy/","people":"Gregory Ferenstein (author, Psychedelics Policy Newsletter); Madison S. Carlino (Policy Analyst, drug policy/psychedelic medicine); Vittorio Nastasi (Director of Criminal Justice Policy)","src":"https://reason.org/psychedelics-policy/","eid":"x:org:reason-foundation-psychedelics-policy-project-los-angeles"},{"id":"reason-for-hope-usa","cat":"industry","name":"Reason for Hope","region":"DC/multi-state (federal + state policy)","country":"United States","cc":"US","lat":39.1441,"lon":-77.0697,"gp":"country","layer":"advocacy","org_type":"nonprofit (policy/legal advocacy + research co-funder)","drugs":["MDMA","psilocybin"],"detail":"The field's most prolific legislative drafter - Freedom to Heal Act (Right to Try), VHA Novel Therapeutics Preparedness Act, state expanded-access pilots (CT passed; PA, NY drafted); also a funder ($1.5M+ to research incl. first MDMA group-therapy trial for…","web":"https://www.reasonforhope.org","people":"Lt. Gen. Martin Steele, USMC (Ret.) (Co-Founder & CEO); Brett Waters, Esq. (Co-Founder & Executive Director); Lynnette Averill, PhD (Co-Founder & Chief Science Officer); Jesse MacLachlan (State…","src":"https://www.reasonforhope.org/","eid":"x:org:reason-for-hope-usa"},{"id":"red-light-holland-corp-toronto","cat":"industry","name":"Red Light Holland Corp.","city":"Toronto","region":"Ontario (HQ); Horst, Limburg (NL production)","country":"Canada","cc":"CA","lat":43.6949,"lon":-79.38805,"gp":"city","layer":"supplier","org_type":"public company (CSE: TRIP) producing/distributing legal psilocybin truffles; parent of Filament Health","drugs":["psilocybin"],"detail":"Largest publicly listed player in the Dutch legal truffle market; April 2026 acquisition of Filament Health links recreational truffle supply to GMP pharma development","email":"todd@redlight.co","web":"https://redlight.co","people":"Todd Shapiro (CEO & Director)","src":"https://redlight.co/","eid":"x:org:red-light-holland-corp-toronto"},{"id":"resilient-pharmaceuticals-fka-lykos-therapeutics-maps-pbc-san-jose","cat":"industry","name":"Resilient Pharmaceuticals (fka Lykos Therapeutics / MAPS PBC)","city":"San Jose","region":"California","country":"United States","cc":"US","lat":37.33774,"lon":-121.89745,"gp":"city","layer":"developer","org_type":"public benefit corporation (drug sponsor)","drugs":["MDMA"],"detail":"Sponsor of the first MDMA-assisted therapy NDA for PTSD; resubmitted to FDA in August 2026 after the 2024 Complete Response Letter.","people":"Michael Mullette (CEO; former COO, became interim CEO after Amy Emerson stepped down 2024)","src":"https://psychedelicalpha.com/news/two-years-after-rejection-resilient-quietly-refiles-mdma-for-ptsd-application/","eid":"x:org:resilient-pharmaceuticals-fka-lykos-therapeutics-maps-pbc-san-jose"},{"id":"reunion-neuroscience-morristown","cat":"industry","name":"Reunion Neuroscience","city":"Morristown","region":"New Jersey","country":"United States","cc":"US","lat":36.22127,"lon":-83.28345,"gp":"city","layer":"developer","org_type":"pharma (private, clinical-stage; MPM BioImpact-backed)","detail":"Leading the postpartum-depression niche: positive Phase 2 RECONNECT (statistically significant Day-7 MADRS benefit), FDA-aligned Phase 3 planned for 2026.","web":"https://reunionneuro.com","people":"Greg Mayes (President & CEO); Nate Bryson (Chief Science Officer)","src":"https://reunionneuro.com/2026/01/12/reunion-neuroscience-announces-program-updates-and-highlights-anticipated-2026-milestones/","eid":"x:org:reunion-neuroscience-morristown"},{"id":"riverstyx-foundation-kirkland","cat":"industry","name":"Riverstyx Foundation","city":"Kirkland","region":"Washington","country":"United States","cc":"US","lat":47.67467,"lon":-122.2182,"gp":"city","layer":"funder","org_type":"Private family foundation (philanthropy)","drugs":["psilocybin","MDMA","mescaline","ayahuasca"],"detail":"Catalytic seed funder of psychedelic science since 2008 — ~$9M to research (incl. early Johns Hopkins psilocybin trials), $4.2M to drug policy reform, $3.1M to Indigenous medicine.","web":"https://www.riverstyxfoundation.org","people":"T. Cody Swift, MFT (Co-Director); Miriam Volat, MS (Co-Director); Kevin Bayuk (Impact Investment Director); Dr. Tanya Kammonen (Program Manager, Indigenous Medicine)","src":"https://www.riverstyxfoundation.org/staff","eid":"x:org:riverstyx-foundation-kirkland"},{"id":"rose-city-laboratories-llc-portland","cat":"industry","name":"Rose City Laboratories, LLC","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52933,"lon":-122.66882,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin testing laboratory (ORELAP-accredited)","drugs":["psilocybin"],"detail":"First (April 2023) and only psilocybin testing lab listed in Oregon's licensee directory - a chokepoint for the entire Oregon supply chain","phone":"503-307-0096","email":"info@rosecitylabs.com","web":"https://www.rosecitylabs.com/psilocybin-testing","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:rose-city-laboratories-llc-portland"},{"id":"rose-hill-life-sciences-jamaica-island-wide-operations-geothermal-enhanced-culti","cat":"industry","name":"Rose Hill Life Sciences","city":"Jamaica (island-wide operations, geothermal-enhanced cultivation)","country":"Jamaica","cc":"JM","lat":18.0813,"lon":-76.5563,"gp":"country","layer":"supplier","org_type":"licensed psilocybin cultivator and exporter (Jamaica; no GMP claim verified)","drugs":["psilocybin"],"detail":"Jamaica's largest legal natural psilocybin producer and self-described world's first legal psilocybin exporter; co-founders advise Jamaica's Psilocybin Mushroom Industry Technical Committee","web":"https://www.rosehill.life","people":"Jama Pitman (CEO, appointed July 2026); Charles Lazarus (co-founder, former CEO); Kevin Bourke (co-founder, Managing Partner & Chief Marketing/Branding Officer)","src":"https://www.globenewswire.com/news-release/2026/07/27/3333624/0/en/Rose-Hill-Life-Sciences-Appoints-Jama-Pitman-as-Chief-Executive-Officer.html","eid":"x:org:rose-hill-life-sciences-jamaica-island-wide-operations-geothermal-enhanced-culti"},{"id":"sacred-spore-company-portland","cat":"industry","name":"Sacred Spore Company","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52896,"lon":-122.68539,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer","drugs":["psilocybin"],"detail":"Licensed cultivator supplying Oregon service centers; publishes manufacturing license # MF-d7892ea8","phone":"971-517-8771","email":"sacredsporeco@gmail.com","web":"https://www.sacredsporeco.com","people":"Matt Freitas (co-founder & CEO); Robert Brady (co-founder & COO)","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:sacred-spore-company-portland"},{"id":"satori-farms-pdx-llc-portland","cat":"industry","name":"Satori Farms PDX, LLC","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.51879,"lon":-122.68012,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer (first in the nation, 2023)","drugs":["psilocybin"],"detail":"Holder of the first legal psilocybin manufacturing license in the US; says it supplies nearly half of Oregon's licensed service centers","phone":"503-728-8205","email":"tori.armbrust@yahoo.com","web":"https://www.satorifarmspdx.com","people":"Tori Armbrust (owner & grower)","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:satori-farms-pdx-llc-portland"},{"id":"satori-neuro-satori-capital-fort-worth","cat":"industry","name":"Satori Neuro (Satori Capital)","city":"Fort Worth","region":"Texas","country":"United States","cc":"US","lat":32.72037,"lon":-97.33003,"gp":"city","layer":"funder","org_type":"VC/mental-health investment strategy of multi-strategy firm","detail":"Mental-health strategy of conscious-capitalism firm Satori Capital; 18+ brain/mental-health investments spanning psychedelics, neurotech, and psychedelic care delivery.","web":"https://www.satoricapital.com/neuro/","people":"Dr. Amy Kruse (Chief Investment Officer, Satori Neuro); Satori Capital co-founders Randy Eisenman and Sunny Vanderbeck (per Business Wire launch release)","src":"https://www.satoricapital.com/neuro/","eid":"x:org:satori-neuro-satori-capital-fort-worth"},{"id":"satya-inc-dba-oregon-psilocybin-growers-collective-ashland","cat":"industry","name":"Satya Inc. dba Oregon Psilocybin Growers Collective","city":"Ashland","region":"Oregon","country":"United States","cc":"US","lat":37.69338,"lon":-122.10345,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer (affiliated with Satya Therapeutics service center)","drugs":["psilocybin"],"detail":"Second manufacturer licensed in Oregon; vertically linked to one of the state's busiest service centers","phone":"541-200-9388","email":"andreas@satyatherapeutics.com","web":"https://satyatherapeutics.com","people":"Jennifer Met (CEO); Andreas Met (COO); Dennis Holden (CFO & Secretary)","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:satya-inc-dba-oregon-psilocybin-growers-collective-ashland"},{"id":"seelos-therapeutics-new-york","cat":"industry","name":"Seelos Therapeutics","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.72382,"lon":-74.00253,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage; in Chapter 11 — effectively defunct)","drugs":["ketamine"],"detail":"Cautionary entry: former intranasal-ketamine developer for acute suicidality/MDD and DoD-funded PTSD work; filed Chapter 11 and is no longer an active industry counterparty.","web":"https://seelostherapeutics.com","people":"Raj Mehra, PhD (Chairman & CEO at time of Chapter 11 filing)","src":"https://www.fiercebiotech.com/biotech/after-als-trial-misses-mark-seelos-has-filed-bankruptcy","eid":"x:org:seelos-therapeutics-new-york"},{"id":"silo-pharma-sarasota","cat":"industry","name":"Silo Pharma","city":"Sarasota","region":"Florida","country":"United States","cc":"US","lat":27.33629,"lon":-82.53041,"gp":"city","layer":"developer","org_type":"pharma (preclinical developmental-stage, Nasdaq: SILO)","drugs":["ketamine"],"detail":"Micro-cap in the psychedelic-adjacent space advancing an intranasal PTSD prophylactic toward IND via the 505(b)(2) pathway.","web":"https://ir.silopharma.com","people":"Eric Weisblum (Founder & CEO)","src":"https://www.globenewswire.com/news-release/2026/06/23/3315946/0/en/Silo-Pharma-Reports-Positive-Stability-Data-for-SPC-15-PTSD-Treatment-Advancing-Program-Toward-First-in-Human-Clinical-Trial.html","eid":"x:org:silo-pharma-sarasota"},{"id":"soundmind-institute-philadelphia","cat":"industry","name":"SoundMind Institute","city":"Philadelphia","region":"Pennsylvania (Philadelphia base); Portland, OR listing on CO DORA roster","country":"United States","cc":"US","lat":39.96118,"lon":-75.15971,"gp":"city","layer":"training","org_type":"Psychedelic training, treatment and research organization","drugs":["psilocybin","ketamine","MDMA"],"detail":"East-coast anchor of facilitator training with West-coast state approvals; multi-molecule curriculum.","phone":"(971) 290-2357 (as published on CO DORA list)","web":"https://www.soundmind.institute","people":"Hannah McLane, MD, MA, MPH (founder & lead instructor)","src":"https://www.soundmind.training/program","eid":"x:org:soundmind-institute-philadelphia"},{"id":"spiritus-oregon-inc-oregon-city-not-published","cat":"industry","name":"Spiritus Oregon, Inc.","city":"Oregon (city not published)","region":"Oregon","country":"United States","cc":"US","lat":41.65142,"lon":-83.47714,"gp":"city","layer":"supplier","org_type":"Oregon OHA-licensed psilocybin manufacturer","drugs":["psilocybin"],"detail":"One of the six manufacturers publicly listed in Oregon's voluntary licensee directory","email":"info@spiritusoregon.com","web":"http://www.spiritusoregon.com","src":"https://psilocybin.oregon.gov/license-directory","eid":"x:org:spiritus-oregon-inc-oregon-city-not-published"},{"id":"steven-alexandra-cohen-foundation-usa","cat":"industry","name":"Steven & Alexandra Cohen Foundation","region":"CT/NY","country":"United States","cc":"US","lat":39.1637,"lon":-76.9521,"gp":"country","layer":"funder","org_type":"Private family foundation (philanthropy)","drugs":["psilocybin","MDMA"],"detail":"Largest private philanthropic funder of psychedelic research — $60M+ committed via its Psychedelic Research & Health Initiative.","web":"https://www.stevenandalexandracohenfoundation.org","people":"Alexandra (Alex) Cohen (President); Steven A. Cohen (Co-founder; Point72 founder)","src":"https://maps.org/2023/06/22/maps-receives-5-million-grant-from-the-steven-alexandra-cohen-foundation/","eid":"x:org:steven-alexandra-cohen-foundation-usa"},{"id":"students-for-sensible-drug-policy-psychedelic-pipeline-washington","cat":"industry","name":"Students for Sensible Drug Policy (Psychedelic Pipeline)","city":"Washington","region":"District of Columbia","country":"United States","cc":"US","lat":38.90222,"lon":-77.03312,"gp":"city","layer":"advocacy","org_type":"501(c)(3) nonprofit (student network; career pipeline + policy reform)","detail":"Workforce on-ramp for the field - mentorship, training scholarships (equity-focused), and a planned training consortium with clinics; also runs a psychedelic policy reform program","phone":"(202) 240-8860","email":"ssdp@ssdp.org","web":"https://ssdp.org","people":"Gina Giorgio (Psychedelic Pipeline Program Director, gina@ssdp.org)","src":"https://ssdp.org/our-work/psychedelic-pipeline/","eid":"x:org:students-for-sensible-drug-policy-psychedelic-pipeline-washington"},{"id":"swiss-federal-office-of-public-health-foph-bag-exceptional-licences-for-banned-n","cat":"industry","name":"Swiss Federal Office of Public Health (FOPH/BAG) — Exceptional Licences for Banned Narcotics","city":"Bern","region":"Bern","country":"Switzerland","cc":"CH","lat":46.95181,"lon":7.43986,"gp":"city","layer":"regulator","org_type":"federal exceptional-authorization office (limited medical use)","drugs":["psilocybin","MDMA","LSD"],"detail":"Runs the world's longest-standing legal psychedelic-therapy channel: per-patient exceptional authorisations since 2014 (psilocybin added 2021); 723 treatment authorisations issued in 2024 (348 psilocybin) across ~100 physicians.","phone":"+41 58 463 88 24","email":"drogen@bag.admin.ch","web":"https://www.bag.admin.ch/en/exceptional-licences-for-banned-narcotics","src":"https://www.bag.admin.ch/en/exceptional-licences-for-banned-narcotics","eid":"x:org:swiss-federal-office-of-public-health-foph-bag-exceptional-licences-for-banned-n"},{"id":"synaptic-institute-portland","cat":"industry","name":"Synaptic Institute","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.52594,"lon":-122.67146,"gp":"city","layer":"training","org_type":"501(c)(3) nonprofit psychedelic training institute","drugs":["psilocybin","ketamine"],"detail":"Early Oregon training nonprofit spanning psilocybin facilitation and KAP certification.","phone":"971-403-0884","email":"info@synaptic.care","web":"https://www.synaptic.institute","src":"https://www.synaptic.institute/","eid":"x:org:synaptic-institute-portland"},{"id":"synthesis-institute-the-resurgence-training-institute-inc-amsterdam-region-nl","cat":"industry","name":"Synthesis Institute (The Resurgence Training Institute Inc.)","city":"Amsterdam region","country":"Netherlands","cc":"NL","lat":52.7681,"lon":5.1387,"gp":"country","kind":"training","drugs":["psilocybin"],"detail":"Relaunched Synthesis brand: 13-month Psychedelic Practitioner Core Training plus legal 5-day psilocybin retreats (1,100+ participants since 2018); research part","web":"https://www.synthesisinstitute.com","people":"Dr Rosalind Watts (Clinical Director)","src":"https://www.synthesisinstitute.com/","layer":"Training programs","eid":"x:org:synthesis-institute-the-resurgence-training-institute-inc-amsterdam-region-nl"},{"id":"tabula-rasa-ventures-new-york","cat":"industry","name":"Tabula Rasa Ventures","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.71159,"lon":-74.01722,"gp":"city","layer":"funder","org_type":"VC fund + incubator (psychedelics)","detail":"First dedicated psychedelic business incubator (Psychedelic Builders) plus early-stage investing; founder Marik Hazan also runs Energia Foundation/Holdings for global psychedelic education.","web":"https://www.tabularasa.ventures","people":"Marik Hazan (Founder & Managing Partner; CEO, Energia Holdings)","src":"https://www.crunchbase.com/organization/tabula-rasa-ventures","eid":"x:org:tabula-rasa-ventures-new-york"},{"id":"terran-biosciences-new-york","cat":"industry","name":"Terran Biosciences","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.71309,"lon":-74.00517,"gp":"city","layer":"developer","org_type":"pharma (private, clinical-stage platform + CNS IP aggregator)","drugs":["psilocybin","MDMA","DMT"],"detail":"IP-and-505(b)(2) strategist: holds the largest portfolio of novel psychedelic salt forms and prodrugs plus late-stage repurposed CNS assets and GMP compound manufacturing.","web":"https://www.terranbiosciences.com","people":"Sam Clark, MD, PhD (Founder & CEO); Dustin Tetzl, MD (Chief Business Officer); Marine Yamada (Senior Manager, Strategy & Operations)","src":"https://www.terranbiosciences.com/","eid":"x:org:terran-biosciences-new-york"},{"id":"the-leela-school-of-awakening-ashland","cat":"industry","name":"The Leela School of Awakening","city":"Ashland","region":"Oregon","country":"United States","cc":"US","lat":37.68792,"lon":-122.11117,"gp":"city","layer":"training","org_type":"OHA-licensed and HECC-approved facilitator training school","drugs":["psilocybin"],"detail":"Established Oregon training school pairing spiritual-teacher lineage with state-licensed curriculum.","phone":"+1 877-584-1165","email":"info@leela.org","web":"https://leelaschool.org/psilocybin-facilitator-program/","people":"Eli Jaxon-Bear (founder, lead educator); Crea Land, MHSc (Program Director); Leigh Estok (Administrative Director)","src":"https://www.leelaschool.org/psilocybin-facilitator-program/","eid":"x:org:the-leela-school-of-awakening-ashland"},{"id":"the-resurgence-training-institute-inc-synthesis-institute-chicago","cat":"industry","name":"The Resurgence Training Institute, Inc. (Synthesis Institute)","city":"Chicago","region":"Illinois (corporate address); online/global delivery","country":"United States","cc":"US","lat":41.85525,"lon":-87.65452,"gp":"city","layer":"training","org_type":"Private psychedelic practitioner training company","drugs":["psilocybin"],"detail":"Revived Synthesis brand operating at scale in Colorado's approved-training roster.","phone":"(800) 927-9800 (as published on CO DORA list)","web":"https://www.synthesisinstitute.com","src":"https://www.synthesisinstitute.com/home","eid":"x:org:the-resurgence-training-institute-inc-synthesis-institute-chicago"},{"id":"therapsil-victoria","cat":"industry","name":"TheraPsil","city":"Victoria","region":"British Columbia","country":"Canada","cc":"CA","lat":48.44084,"lon":-123.3484,"gp":"city","layer":"advocacy","org_type":"nonprofit patient-access advocacy coalition","drugs":["psilocybin"],"detail":"Canada's flagship medical psilocybin access group - won the first s.56(1) CDSA exemptions (2020), now shepherds patients/clinicians through Health Canada's Special Access Program and pursues a Charter challenge for a right to medical psilocybin","email":"support@therapsil.ca (general); john@therapsil.ca (media)","web":"https://therapsil.ca","people":"Spencer Hawkswell (CEO); Dr. Bruce Tobin (Founder & Board Chair); Yasmeen deRosenroll (COO); John Gilchrist (Director of Communications)","src":"https://therapsil.ca/our-team/","eid":"x:org:therapsil-victoria"},{"id":"therapeutic-goods-administration-tga-authorised-prescriber-scheme-mdma-psilocybi","cat":"industry","name":"Therapeutic Goods Administration (TGA) — Authorised Prescriber Scheme (MDMA & psilocybine)","city":"Canberra (Woden)","region":"ACT","country":"Australia","cc":"AU","lat":-35.2933,"lon":149.12501,"gp":"city","layer":"regulator","org_type":"national medicines regulator (unapproved-goods access scheme)","drugs":["psilocybin","MDMA"],"detail":"Since July 1, 2023, authorises psychiatrists (with HREC approval) to prescribe MDMA and psilocybine outside trials — the world's first national down-scheduling; the contact point for every AU supplier and prescriber.","phone":"1800 020 653","email":"info@tga.gov.au","web":"https://www.tga.gov.au/products/unapproved-therapeutic-goods/mdma-and-psilocybine","src":"https://www.tga.gov.au/products/unapproved-therapeutic-goods/mdma-and-psilocybine/access-pathways/prescribe-mdma-or-psilocybine-psychiatrists","eid":"x:org:therapeutic-goods-administration-tga-authorised-prescriber-scheme-mdma-psilocybi"},{"id":"tim-ferriss-saisei-foundation-austin","cat":"industry","name":"Tim Ferriss (Saisei Foundation)","city":"Austin","region":"Texas","country":"United States","cc":"US","lat":30.26428,"lon":-97.75468,"gp":"city","layer":"funder","org_type":"Individual philanthropist","drugs":["psilocybin"],"detail":"Catalytic individual donor who spearheaded the $17M founding of the Johns Hopkins Center for Psychedelic & Consciousness Research and helped mainstream psychedelic science funding.","web":"https://tim.blog","people":"Tim Ferriss (donor; author/investor)","src":"https://www.insidephilanthropy.com/home/2019-10-1-braver-and-bolder-steps-behind-a-big-gift-to-support-the-burgeoning-field-of-psychedelic-research","eid":"x:org:tim-ferriss-saisei-foundation-austin"},{"id":"transcend-therapeutics-now-wholly-owned-by-otsuka-new-york","cat":"industry","name":"Transcend Therapeutics (now wholly owned by Otsuka)","city":"New York","region":"New York","country":"United States","cc":"US","lat":40.70265,"lon":-73.99538,"gp":"city","layer":"developer","org_type":"pharma (clinical-stage; Otsuka America subsidiary since Jun 2026)","detail":"First psychedelic-adjacent M&A exit to Japanese pharma: Otsuka paid $700M upfront (up to $1.225B total) for the Phase 3-stage methylone PTSD program.","web":"https://transcendtherapeutics.com","people":"Blake Mandell (Co-founder & CEO)","src":"https://www.otsuka.co.jp/en/company/newsreleases/2026/20260327_2.html","eid":"x:org:transcend-therapeutics-now-wholly-owned-by-otsuka-new-york"},{"id":"turnbull-family-foundation-greenwich","cat":"industry","name":"Turnbull Family Foundation","city":"Greenwich","region":"Connecticut","country":"United States","cc":"US","lat":41.01703,"lon":-73.63237,"gp":"city","layer":"funder","org_type":"Private family foundation (philanthropy)","drugs":["psilocybin","LSD"],"detail":"Philanthropic vehicle of Carey Turnbull, who has donated ~$20M to psychedelic research (NYU, Yale) and also leads Heffter, Ceruvia Lifesciences, B.More, and Freedom to Operate.","people":"Carey Turnbull (Director/Chair/Treasurer/Secretary per Form 990 profile; also President of Heffter Research Institute, Chair of NYU Center for Psychedelic Medicine advisory board)","src":"https://www.lucid.news/carey-turnbull-donor-investor/","eid":"x:org:turnbull-family-foundation-greenwich"},{"id":"uc-berkeley-center-for-the-science-of-psychedelics-bcsp-berkeley","cat":"industry","name":"UC Berkeley Center for the Science of Psychedelics (BCSP)","city":"Berkeley","region":"California","country":"United States","cc":"US","lat":37.86345,"lon":-122.26734,"gp":"city","layer":"advocacy","org_type":"university research center (public education/journalism arm)","drugs":["psilocybin"],"detail":"The field's most credible public-education engine - Michael Pollan co-founded it in 2020; The Microdose newsletter and Psychedelics 101 shape mainstream and policymaker understanding; also incubated a facilitation certificate program","phone":"415-385-3687 (development office)","email":"BCSPmedia@berkeley.edu (media); BCSPresearchsubjects@berkeley.edu (research)","web":"https://psychedelics.berkeley.edu","people":"Michael Silver (Faculty Director); Andrea Venezia (Executive Director); Michael Pollan (Co-Founder; Advisory Council); Malia Wollan (Editor in Chief, Journalism Projects); Jane C. Hu (Head Writer,…","src":"https://psychedelics.berkeley.edu/leadership-staff/","eid":"x:org:uc-berkeley-center-for-the-science-of-psychedelics-bcsp-berkeley"},{"id":"upheal-new-york-prague","cat":"industry","name":"Upheal","city":"New York / Prague","country":"United States","cc":"US","lat":39.2343,"lon":-77.5168,"gp":"country","layer":"tech","org_type":"AI scribe / session-recording platform for mental-health clinicians","detail":"Leading session-recording + AI-notes vendor in the therapist stack (36,000+ mental-health professionals; transcription, SOAP/DAP/BIRP/GIRP notes, session analytics) — the generic scribe layer psychedelic therapists draw on; no psychedelic-specific product…","web":"https://www.upheal.io/","people":"Juraj Chrappa (co-founder & CEO); Martin Horvath (co-founder)","src":"https://www.vestbee.com/insights/articles/upheal-secures-10-m","eid":"x:org:upheal-new-york-prague"},{"id":"usona-institute-madison-fitchburg-campus","cat":"industry","name":"Usona Institute","city":"Madison (Fitchburg campus)","region":"Wisconsin","country":"United States","cc":"US","lat":43.06839,"lon":-89.40947,"gp":"city","layer":"supplier","org_type":"501(c)(3) nonprofit medical research organization / GMP psilocybin developer-supplier","drugs":["psilocybin","5-MeO-DMT"],"detail":"Nonprofit that manufactures/supplies GMP psilocybin for research (investigational drug supply program) and runs the largest Phase 3 psilocybin-for-MDD trial","web":"https://www.usonainstitute.org","people":"Bill Linton (co-founder, 2014; founder of Promega); Malynn Utzinger, MD (co-founder)","src":"https://en.wikipedia.org/wiki/Usona_Institute","eid":"x:org:usona-institute-madison-fitchburg-campus"},{"id":"usona-institute-fitchburg-madison-area","cat":"industry","name":"Usona Institute","city":"Fitchburg (Madison area)","region":"Wisconsin","country":"United States","cc":"US","lat":42.59467,"lon":-71.79783,"gp":"city","layer":"developer","org_type":"nonprofit medical research organization (drug sponsor)","drugs":["psilocybin"],"detail":"The nonprofit sponsor of psilocybin for major depressive disorder — Phase 3 uAspire trial underway with FDA Breakthrough Therapy designation.","web":"https://www.usonainstitute.org","people":"Bill Linton (Co-founder & Executive Director; also founder/CEO of Promega); Charles 'Chuck' Raison, MD (Director of Clinical and Translational Research)","src":"https://www.usonainstitute.org/psilocybin","eid":"x:org:usona-institute-fitchburg-madison-area"},{"id":"vets-inc-veterans-exploring-treatment-solutions-southlake","cat":"industry","name":"VETS, Inc. (Veterans Exploring Treatment Solutions)","city":"Southlake","region":"Texas","country":"United States","cc":"US","lat":32.93517,"lon":-97.13272,"gp":"city","layer":"funder","org_type":"501(c)(3) nonprofit (treatment grant program + policy advocacy)","drugs":["ibogaine","DMT"],"detail":"Flagship demand-side funder: Foundational Healing Grants send special-operations veterans to legal ibogaine/5-MeO-DMT treatment abroad; central to the $100M+ Texas Ibogaine Initiative and $124M+ in public psychedelic-research funding","web":"https://vetsolutions.org","people":"Marcus Capone (Co-Founder, Chair of the Board); Amber Capone (Co-Founder & CEO); Robert Corley (COO); Logan Davidson (Director of Policy & Advocacy); John Clifton, MD (Director of Research &…","src":"https://vetsolutions.org/team/","eid":"x:org:vets-inc-veterans-exploring-treatment-solutions-southlake"},{"id":"valor-minds-englewood","cat":"industry","name":"Valor Minds","city":"Englewood","region":"Colorado","country":"United States","cc":"US","lat":39.64772,"lon":-104.98875,"gp":"city","layer":"supplier","org_type":"Colorado natural medicine cultivation venture (early NMD-approved applicant)","drugs":["psilocybin"],"detail":"Among the first Colorado cultivation applicants approved by the Natural Medicine Division; planned supplier to licensed healing centers","people":"Troy Leonard (CEO; Marine Corps veteran)","src":"https://coloradonewsline.com/2025/01/06/colorado-licenses-psychedelic-mushroom-facilitators/","eid":"x:org:valor-minds-englewood"},{"id":"vancouver-island-university-psychedelic-assisted-therapy-graduate-certificate-na","cat":"industry","name":"Vancouver Island University — Psychedelic-Assisted Therapy Graduate Certificate","city":"Nanaimo","region":"BC","country":"Canada","cc":"CA","lat":49.17424,"lon":-123.94347,"gp":"city","kind":"training","drugs":["ketamine","MDMA","psilocybin"],"detail":"Graduate certificate training program for psychedelic-assisted therapy practitioners (launched Sept 2022), curriculum built on the Roots to Thrive care model; d","phone":"250-753-3245","web":"https://www.viu.ca/programs/health/psychedelic-assisted-therapy","people":"Dr. Shannon Dames (co-developer); Dr. Pamela Kryskow (medical lead)","src":"https://news.viu.ca/viu-establishes-new-psychedelic-assisted-therapy-program","layer":"Training programs","eid":"x:org:vancouver-island-university-psychedelic-assisted-therapy-graduate-certificate-na"},{"id":"veteran-mental-health-leadership-coalition-vmhlc-usa","cat":"industry","name":"Veteran Mental Health Leadership Coalition (VMHLC)","country":"United States","cc":"US","lat":38.6186,"lon":-76.7207,"gp":"country","layer":"advocacy","org_type":"501(c)(19) veteran-member coalition","drugs":["MDMA","psilocybin"],"detail":"Umbrella coalition (10+ orgs incl. Heroic Hearts, Navy SEAL Foundation, Fireside Project, BrainFutures) pushing expanded access to psychedelic-assisted therapy for veterans - concentrated political cover for the field","web":"https://www.vmhlc.org","people":"Lt. Gen. Martin Steele, USMC (Ret.) (coalition leader; CEO of Reason for Hope); Brett Waters, Esq. (Co-Founder); Adam Marr (Director of Operations, founding member)","src":"https://www.vmhlc.org/","eid":"x:org:veteran-mental-health-leadership-coalition-vmhlc-usa"},{"id":"vicente-llp-denver","cat":"industry","name":"Vicente LLP","city":"Denver","region":"CO (offices incl. Boston, LA, NY, NJ, Austin, Portland OR)","country":"United States","cc":"US","lat":39.73242,"lon":-104.97317,"gp":"city","layer":"legal","org_type":"Law firm (cannabis & psychedelics boutique)","drugs":["psilocybin","MDMA","ketamine","DMT","ibogaine","mescaline"],"detail":"The dominant dedicated cannabis/psychedelics firm in the US: licensure, regulatory compliance, entity formation for psychedelics businesses; drafted CO Prop 122; absorbed Emerge Law Group's Measure 109 psilocybin team into a new Oregon office; 7 attorneys on…","web":"https://vicentellp.com/","people":"Joshua Kappel (Founding Partner; co-author of Colorado Prop 122 Natural Medicine Health Act; Chambers Band 1 Psychedelics Law); Brian Vicente (Founding Partner); Christian Sederberg (Founding…","src":"https://vicentellp.com/services/psychedelics/","eid":"x:org:vicente-llp-denver"},{"id":"vine-ventures-new-york","cat":"industry","name":"Vine Ventures","city":"New York","country":"United States","cc":"US","lat":40.72476,"lon":-74.00621,"gp":"city","layer":"funder","org_type":"VC fund (early-stage psychedelics/wellness)","drugs":["MDMA","psilocybin"],"detail":"Pioneered the $70M Regenerative Financing Vine SPV that funded MAPS/Lykos MDMA-assisted-therapy Phase 3 and launch — the field's most novel nonprofit/for-profit capital structure.","web":"https://www.vine.vc","people":"Ryan Zurrer (Founder & Managing Director); Ozan Polat (Investor); Fede Menapace (MAPS counterpart on RFV deal, for reference)","src":"https://maps.org/2021/12/02/maps-and-vine-ventures-pioneer-novel-regenerative-financing/","eid":"x:org:vine-ventures-new-york"},{"id":"wavepaths-london","cat":"industry","name":"Wavepaths","city":"London","country":"United Kingdom","cc":"GB","lat":51.50415,"lon":-0.12927,"gp":"city","layer":"tech","org_type":"adaptive session-music software","drugs":["ketamine","psilocybin","MDMA"],"detail":"Owns the in-session music layer: person-centred, real-time-adaptive therapeutic music for psychedelic and ketamine sessions, with exclusive compositions (Brian Eno, Jon Hopkins collaborations) plus 'Foundations of Therapeutic Music' practitioner training","web":"https://wavepaths.com/","people":"Dr. Mendel Kaelen (founder & CEO; ex-Imperial College London psychedelic-music neuroscientist); Anna Wakefield/Rickman (co-founder, per company story and 2021 funding PR)","src":"https://wavepaths.com/","eid":"x:org:wavepaths-london"},{"id":"weaving-bridges-natural-fellowship-psilocybin-facilitator-training-program-portl","cat":"industry","name":"Weaving Bridges Natural Fellowship Psilocybin Facilitator Training Program","city":"Portland","region":"Oregon","country":"United States","cc":"US","lat":45.51296,"lon":-122.67381,"gp":"city","layer":"training","org_type":"Facilitator training program","drugs":["psilocybin"],"detail":"Approved-curriculum holder rounding out the complete official Oregon roster.","src":"https://psilocybin.oregon.gov/training-approved","eid":"x:org:weaving-bridges-natural-fellowship-psilocybin-facilitator-training-program-portl"},{"id":"xeia-venture-partners-formerly-empath-ventures-los-angeles","cat":"industry","name":"XEIA Venture Partners (formerly Empath Ventures)","city":"Los Angeles","region":"California","country":"United States","cc":"US","lat":34.0535,"lon":-118.25041,"gp":"city","layer":"funder","org_type":"VC fund (pre-seed/seed)","detail":"Brom Rector's psychedelic-focused Empath Ventures, rebranded to XEIA with a broadened 'Human 3' health/AI/deep-tech thesis while retaining its psychedelic portfolio.","web":"https://www.xeiavp.com","people":"Brom Rector, CFA (Founding Partner); Sam Rector (Partner, medicinal chemist); Li-Huei Tsai, PhD (Scientific Advisor, MIT Aging Brain Initiative)","src":"https://www.xeiavp.com/","eid":"x:org:xeia-venture-partners-formerly-empath-ventures-los-angeles"},{"id":"zuber-lawler-llp-los-angeles","cat":"industry","name":"Zuber Lawler LLP","city":"Los Angeles","region":"California","country":"United States","cc":"US","lat":34.04776,"lon":-118.2441,"gp":"city","layer":"legal","org_type":"Law firm (IP, M&A, litigation; dedicated psychedelics practice)","drugs":["psilocybin"],"detail":"Established full-service firm with a named psychedelics practice covering FDA compliance, IP, M&A, finance, healthcare, and product liability for psychedelics companies; longtime cannabis-industry counsel.","phone":"(213) 596-5620","email":"contact@zuberlawler.com","web":"https://zuberlawler.com/","people":"Tom Zuber (Managing Partner & co-founder; board member, Psychedelic Medicine Coalition)","src":"https://zuberlawler.com/practice_area/psychedelics-attorneys/","eid":"x:org:zuber-lawler-llp-los-angeles"},{"id":"re-mind-capital-london","cat":"industry","name":"re.Mind Capital","city":"London","country":"United Kingdom","cc":"GB","lat":51.50039,"lon":-0.1272,"gp":"city","layer":"funder","org_type":"VC fund (mental health / family-office venture arm)","detail":"Mental-health venture arm of Christian Angermayer's Apeiron Investment Group — Angermayer co-founded atai Life Sciences and seed-funded COMPASS Pathways, making this a central node of psychedelic capital.","email":"team@remind.vc; info@remind.vc","web":"https://remind.vc","people":"Christian Angermayer (Founder); Jan Hardorp (Founding Partner); Max de Vere (Partner) — per press/LinkedIn","src":"https://remind.vc/","eid":"x:org:re-mind-capital-london"}]}